There were significant differences in s - VEGF between the RCC patients and the controls ( 207. 3 + / - 32. 9 vs. 71. 5 + / - 9. 1 pg / ml, mean + / - SE) ( P less than 0. 005), between the tumor - bearing renal veins and the contralateral ones ( P less than 0. 01), between the pre - and post - nephrectomy situations ( P less than 0. 01) and among the various parameters of tumor status such as tumor extent ( P less than 0. 001) and existence of metastasis ( P less than 0. 001).	"VEGF	42	46	Gene_or_gene_product"	"RCC	59	62	Cancer"	"patients	63	71	Organism"	"tumor	190	195	Cancer"	"renal veins	206	217	Multi"	"tumor	376	381	Cancer"	"tumor	397	402	Cancer"	"[{""token"": ""VEGF"", ""start_span"": 42, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""RCC"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Cancer""}, {""token"": ""renal veins"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Multi""}, {""token"": ""tumor"", ""start_span"": 376, ""end_span"": 381, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 397, ""end_span"": 402, ""type"": ""Cancer""}]"
LMP1 of Epstein - Barr virus induces proliferation of primary mouse embryonic fibroblasts and cooperatively transforms the cells with a p16 - insensitive CDK4 oncogene.	"LMP1	0	4	Gene_or_gene_product"	"Epstein - Barr virus	8	28	Organism"	"mouse	62	67	Organism"	"embryonic fibroblasts	68	89	Cell"	"cells	123	128	Cell"	"p16	136	139	Gene_or_gene_product"	"CDK4	154	158	Gene_or_gene_product"	"[{""token"": ""LMP1"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 8, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""mouse"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""embryonic fibroblasts"", ""start_span"": 68, ""end_span"": 89, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""p16"", ""start_span"": 136, ""end_span"": 139, ""type"": ""Gene_or_gene_product""}, {""token"": ""CDK4"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}]"
The latent membrane protein LMP1 of Epstein - Barr virus ( EBV) is often present in EBV - associated malignancies including nasopharyngeal carcinoma and Hodgkin ' s lymphoma.	"LMP1	28	32	Gene_or_gene_product"	"Epstein - Barr virus	36	56	Organism"	"EBV	59	62	Organism"	"EBV	84	87	Organism"	"malignancies	101	113	Cancer"	"nasopharyngeal carcinoma	124	148	Cancer"	"Hodgkin ' s lymphoma	153	173	Cancer"	"[{""token"": ""LMP1"", ""start_span"": 28, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""Epstein - Barr virus"", ""start_span"": 36, ""end_span"": 56, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Organism""}, {""token"": ""malignancies"", ""start_span"": 101, ""end_span"": 113, ""type"": ""Cancer""}, {""token"": ""nasopharyngeal carcinoma"", ""start_span"": 124, ""end_span"": 148, ""type"": ""Cancer""}, {""token"": ""Hodgkin ' s lymphoma"", ""start_span"": 153, ""end_span"": 173, ""type"": ""Cancer""}]"
This is primarily based on limited in vitro studies on tumor cells derived from transitional cell carcinoma of the bladder that revealed a dose - and time - dependent inhibition of cell growth by ciprofloxacin at concentrations that are easily attainable in the urine of patients.	"tumor cells	55	66	Cell"	"transitional cell carcinoma	80	107	Cancer"	"bladder	115	122	Organ"	"cell	181	185	Cell"	"ciprofloxacin	196	209	Chemical"	"urine	262	267	Organism_substance"	"patients	271	279	Organism"	"[{""token"": ""tumor cells"", ""start_span"": 55, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""transitional cell carcinoma"", ""start_span"": 80, ""end_span"": 107, ""type"": ""Cancer""}, {""token"": ""bladder"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Organ""}, {""token"": ""cell"", ""start_span"": 181, ""end_span"": 185, ""type"": ""Cell""}, {""token"": ""ciprofloxacin"", ""start_span"": 196, ""end_span"": 209, ""type"": ""Chemical""}, {""token"": ""urine"", ""start_span"": 262, ""end_span"": 267, ""type"": ""Organism_substance""}, {""token"": ""patients"", ""start_span"": 271, ""end_span"": 279, ""type"": ""Organism""}]"
This study uses quantitative histomorphometry and double - immunohistologic detection techniques for the demarcation of proliferating endothelial cells, to show that synchronized hair follicle cycling in adolescent C57BL / 6 mice is associated with substantial angiogenesis, and that inhibiting angiogenesis in vivo by the intraperitoneal application of a fumagillin derivative retards experimentally induced anagen development in these mice.	"endothelial cells	134	151	Cell"	"hair follicle	179	192	Multi"	"C57BL / 6 mice	215	229	Organism"	"intraperitoneal	323	338	Immaterial_anatomical_entity"	"fumagillin derivative	356	377	Chemical"	"anagen	409	415	Multi"	"mice	437	441	Organism"	"[{""token"": ""endothelial cells"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Cell""}, {""token"": ""hair follicle"", ""start_span"": 179, ""end_span"": 192, ""type"": ""Multi""}, {""token"": ""C57BL / 6 mice"", ""start_span"": 215, ""end_span"": 229, ""type"": ""Organism""}, {""token"": ""intraperitoneal"", ""start_span"": 323, ""end_span"": 338, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""fumagillin derivative"", ""start_span"": 356, ""end_span"": 377, ""type"": ""Chemical""}, {""token"": ""anagen"", ""start_span"": 409, ""end_span"": 415, ""type"": ""Multi""}, {""token"": ""mice"", ""start_span"": 437, ""end_span"": 441, ""type"": ""Organism""}]"
In order to study their relation to the metastatic profile and survival, we evaluated the association between pretreatment serum levels of S - 100beta, IL - 6, IL - 10 and IL - 12 and metastatic site and survival in 50 patients with advanced melanoma who were to receive chemoimmunotherapy.	"serum	123	128	Organism_substance"	"S - 100beta	139	150	Gene_or_gene_product"	"IL - 6	152	158	Gene_or_gene_product"	"IL - 10	160	167	Gene_or_gene_product"	"IL - 12	172	179	Gene_or_gene_product"	"patients	219	227	Organism"	"melanoma	242	250	Cancer"	"[{""token"": ""serum"", ""start_span"": 123, ""end_span"": 128, ""type"": ""Organism_substance""}, {""token"": ""S - 100beta"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 152, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 160, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 12"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""patients"", ""start_span"": 219, ""end_span"": 227, ""type"": ""Organism""}, {""token"": ""melanoma"", ""start_span"": 242, ""end_span"": 250, ""type"": ""Cancer""}]"
The findings suggest that elevated serum levels of S - 100beta, IL - 6 and IL - 10 reflect concurrent liver or bone metastases in melanoma.	"serum	35	40	Organism_substance"	"S - 100beta	51	62	Gene_or_gene_product"	"IL - 6	64	70	Gene_or_gene_product"	"IL - 10	75	82	Gene_or_gene_product"	"liver	102	107	Organ"	"bone	111	115	Organ"	"melanoma	130	138	Cancer"	"[{""token"": ""serum"", ""start_span"": 35, ""end_span"": 40, ""type"": ""Organism_substance""}, {""token"": ""S - 100beta"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 6"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 10"", ""start_span"": 75, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 102, ""end_span"": 107, ""type"": ""Organ""}, {""token"": ""bone"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Organ""}, {""token"": ""melanoma"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Cancer""}]"
TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras - transformed cells while repressing the transcription of stromelysin - 1.	"TEL	0	3	Gene_or_gene_product"	"tumor	16	21	Cancer"	"cell	44	48	Cell"	"cell	60	64	Cell"	"ras	79	82	Gene_or_gene_product"	"cells	97	102	Cell"	"stromelysin - 1	141	156	Gene_or_gene_product"	"[{""token"": ""TEL"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 44, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 60, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""ras"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Cell""}, {""token"": ""stromelysin - 1"", ""start_span"": 141, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"
We present evidence that apoptosis of caspase - 3 - deficient MCF - 7 breast cancer cells is defective in response to cisplatin treatment, as determined by chromatin condensation, nuclear fragmentation, DNA fragmentation, and release of cytochrome c from the mitochondria.	"caspase - 3	38	49	Gene_or_gene_product"	"cisplatin	118	127	Chemical"	"chromatin	156	165	Cellular_component"	"nuclear	180	187	Cellular_component"	"DNA	203	206	Cellular_component"	"cytochrome c	237	249	Gene_or_gene_product"	"mitochondria	259	271	Cellular_component"	"[{""token"": ""caspase - 3"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Gene_or_gene_product""}, {""token"": ""cisplatin"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Chemical""}, {""token"": ""chromatin"", ""start_span"": 156, ""end_span"": 165, ""type"": ""Cellular_component""}, {""token"": ""nuclear"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Cellular_component""}, {""token"": ""DNA"", ""start_span"": 203, ""end_span"": 206, ""type"": ""Cellular_component""}, {""token"": ""cytochrome c"", ""start_span"": 237, ""end_span"": 249, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 259, ""end_span"": 271, ""type"": ""Cellular_component""}]"
PROCEDURE: To investigate the effect of p75 expression in NB, we transfected the p75 cDNA into SH - SY5Y cells, an NB cell line lacking expression of both p75 and TrkA.	"p75	40	43	Gene_or_gene_product"	"NB	58	60	Cancer"	"p75	81	84	Gene_or_gene_product"	"SH - SY5Y cells	95	110	Cell"	"NB cell line	115	127	Cell"	"p75	155	158	Gene_or_gene_product"	"TrkA	163	167	Gene_or_gene_product"	"[{""token"": ""p75"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""NB"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Cancer""}, {""token"": ""p75"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene_or_gene_product""}, {""token"": ""SH - SY5Y cells"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""NB cell line"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Cell""}, {""token"": ""p75"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""TrkA"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}]"
The soluble factors they release in its presence arrest the cycle of endothelial cells ( EC), inhibit in vitro angiogenesis, negatively modulate the production of matrix metalloproteinase - 9, and the ability of EC to adhere to vitronectin and up - regulate ICAM - 1 and VCAM - 1 expression.	"endothelial cells	69	86	Cell"	"EC	89	91	Cell"	"matrix metalloproteinase - 9	163	191	Gene_or_gene_product"	"EC	212	214	Cell"	"vitronectin	228	239	Gene_or_gene_product"	"ICAM - 1	258	266	Gene_or_gene_product"	"VCAM - 1	271	279	Gene_or_gene_product"	"[{""token"": ""endothelial cells"", ""start_span"": 69, ""end_span"": 86, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 163, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 212, ""end_span"": 214, ""type"": ""Cell""}, {""token"": ""vitronectin"", ""start_span"": 228, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}, {""token"": ""ICAM - 1"", ""start_span"": 258, ""end_span"": 266, ""type"": ""Gene_or_gene_product""}, {""token"": ""VCAM - 1"", ""start_span"": 271, ""end_span"": 279, ""type"": ""Gene_or_gene_product""}]"
Inhibition of PDGF - stimulated and matrix - mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin - dependent kinase inhibitors.	"PDGF	14	18	Gene_or_gene_product"	"matrix	36	42	Cellular_component"	"human	71	76	Organism"	"vascular smooth muscle cells	77	105	Cell"	"SPARC	109	114	Gene_or_gene_product"	"cell	144	148	Cell"	"cyclin - dependent kinase inhibitors	158	194	Chemical"	"[{""token"": ""PDGF"", ""start_span"": 14, ""end_span"": 18, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Cellular_component""}, {""token"": ""human"", ""start_span"": 71, ""end_span"": 76, ""type"": ""Organism""}, {""token"": ""vascular smooth muscle cells"", ""start_span"": 77, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""SPARC"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""cyclin - dependent kinase inhibitors"", ""start_span"": 158, ""end_span"": 194, ""type"": ""Chemical""}]"
METHODS: Tumor biopsy specimens and serum were obtained from 37 neuroblastoma patients; adrenal biopsy sections and sera of 7 normal children served as controls.	"Tumor biopsy specimens	9	31	Cancer"	"serum	36	41	Organism_substance"	"neuroblastoma	64	77	Cancer"	"patients	78	86	Organism"	"adrenal biopsy sections	88	111	Multi"	"sera	116	120	Organism_substance"	"children	133	141	Organism"	"[{""token"": ""Tumor biopsy specimens"", ""start_span"": 9, ""end_span"": 31, ""type"": ""Cancer""}, {""token"": ""serum"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Organism_substance""}, {""token"": ""neuroblastoma"", ""start_span"": 64, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 78, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""adrenal biopsy sections"", ""start_span"": 88, ""end_span"": 111, ""type"": ""Multi""}, {""token"": ""sera"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Organism_substance""}, {""token"": ""children"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Organism""}]"
Dietary CLA decreased serum levels of vascular endothelial growth factor ( VEGF) and whole mammary gland levels of VEGF and its receptor Flk - 1.	"CLA	8	11	Chemical"	"serum	22	27	Organism_substance"	"vascular endothelial growth factor	38	72	Gene_or_gene_product"	"VEGF	75	79	Gene_or_gene_product"	"mammary gland	91	104	Organ"	"VEGF	115	119	Gene_or_gene_product"	"Flk - 1	137	144	Gene_or_gene_product"	"[{""token"": ""CLA"", ""start_span"": 8, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""serum"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism_substance""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 38, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammary gland"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Organ""}, {""token"": ""VEGF"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""Flk - 1"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}]"
Histologic evaluation revealed that although tumors overexpressing TIMP - 3 had an increased number of CD31 ( +) endothelial cells, these endothelial cells had not formed functional tubules, as evidenced by decreased vessel continuity and minimal pericyte recruitment.	"tumors	45	51	Cancer"	"TIMP - 3	67	75	Gene_or_gene_product"	"CD31	103	107	Gene_or_gene_product"	"endothelial cells	113	130	Cell"	"tubules	182	189	Tissue"	"vessel	217	223	Multi"	"pericyte	247	255	Cell"	"[{""token"": ""tumors"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""TIMP - 3"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD31"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 113, ""end_span"": 130, ""type"": ""Cell""}, {""token"": ""tubules"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Tissue""}, {""token"": ""vessel"", ""start_span"": 217, ""end_span"": 223, ""type"": ""Multi""}, {""token"": ""pericyte"", ""start_span"": 247, ""end_span"": 255, ""type"": ""Cell""}]"
Looking for mechanisms linking Brn - 3a to carcinogenesis, we discuss the role of this transcription factor in influencing Bcl - 2 / p53 antagonism and Bcl - 2 / VEGF induction of tumor angiogenesis, concluding this review with a proposal for the oncogenic nature of Brn - 3a.	"Brn - 3a	31	39	Gene_or_gene_product"	"Bcl - 2	123	130	Gene_or_gene_product"	"p53	133	136	Gene_or_gene_product"	"Bcl - 2	152	159	Gene_or_gene_product"	"VEGF	162	166	Gene_or_gene_product"	"tumor	180	185	Cancer"	"Brn - 3a	267	275	Gene_or_gene_product"	"[{""token"": ""Brn - 3a"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 133, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 180, ""end_span"": 185, ""type"": ""Cancer""}, {""token"": ""Brn - 3a"", ""start_span"": 267, ""end_span"": 275, ""type"": ""Gene_or_gene_product""}]"
F - 2 cells cultured on Matrigel showed evident tube formation, and coculture of F - 2 cells with A431 cells led to the formation of A431 cell nests constantly surrounded by tube - like networks consisting of F - 2 cells.	"F - 2 cells	0	11	Cell"	"tube	48	52	Tissue"	"F - 2 cells	81	92	Cell"	"A431 cells	98	108	Cell"	"A431 cell	133	142	Cell"	"tube	174	178	Tissue"	"F - 2 cells	209	220	Cell"	"[{""token"": ""F - 2 cells"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 48, ""end_span"": 52, ""type"": ""Tissue""}, {""token"": ""F - 2 cells"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""A431 cells"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""A431 cell"", ""start_span"": 133, ""end_span"": 142, ""type"": ""Cell""}, {""token"": ""tube"", ""start_span"": 174, ""end_span"": 178, ""type"": ""Tissue""}, {""token"": ""F - 2 cells"", ""start_span"": 209, ""end_span"": 220, ""type"": ""Cell""}]"
These results indicate that the interaction of tumor cells and endothelial cells in orderly tumor angiomorphogenesis is highly dependent on the action of cell adhesion molecules mediating the adhesion of cancer cells to endothelial cells, inhibition of which remarkably retards tumor growth and angiogenesis.	"tumor cells	47	58	Cell"	"endothelial cells	63	80	Cell"	"tumor	92	97	Cancer"	"cell	154	158	Cell"	"cancer cells	204	216	Cell"	"endothelial cells	220	237	Cell"	"tumor	278	283	Cancer"	"[{""token"": ""tumor cells"", ""start_span"": 47, ""end_span"": 58, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""cell"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 204, ""end_span"": 216, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 220, ""end_span"": 237, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Cancer""}]"
We investigated the roles of the prostaglandin synthases cyclooxygenase ( COX) I and COX - II in angiogenesis and progesterone production in the newly formed CL, using inhibitors of the COX enzymes and the gonadotropin - induced pseudopregnant rat as a model.	"prostaglandin	33	46	Chemical"	"COX - II	85	93	Gene_or_gene_product"	"progesterone	114	126	Chemical"	"CL	158	160	Multi"	"COX enzymes	186	197	Gene_or_gene_product"	"gonadotropin	206	218	Gene_or_gene_product"	"rat	244	247	Organism"	"[{""token"": ""prostaglandin"", ""start_span"": 33, ""end_span"": 46, ""type"": ""Chemical""}, {""token"": ""COX - II"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""progesterone"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Chemical""}, {""token"": ""CL"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Multi""}, {""token"": ""COX enzymes"", ""start_span"": 186, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""gonadotropin"", ""start_span"": 206, ""end_span"": 218, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Organism""}]"
BACKGROUND & # 38; OBJECTIVE: It has been proved that Epstein - Barr virus ( EBV) latent membrane protein 1 ( EBV - LMP1) can induce the expression of matrix metalloproteinase - 9 ( MMP - 9).	"Epstein - Barr virus	54	74	Organism"	"EBV	77	80	Organism"	"latent membrane protein 1	82	107	Gene_or_gene_product"	"EBV	110	113	Organism"	"LMP1	116	120	Gene_or_gene_product"	"matrix metalloproteinase - 9	151	179	Gene_or_gene_product"	"MMP - 9	182	189	Gene_or_gene_product"	"[{""token"": ""Epstein - Barr virus"", ""start_span"": 54, ""end_span"": 74, ""type"": ""Organism""}, {""token"": ""EBV"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Organism""}, {""token"": ""latent membrane protein 1"", ""start_span"": 82, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""EBV"", ""start_span"": 110, ""end_span"": 113, ""type"": ""Organism""}, {""token"": ""LMP1"", ""start_span"": 116, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""matrix metalloproteinase - 9"", ""start_span"": 151, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 182, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}]"
RESULTS: Adenoviral transduction of endothelial cells with pAd - Survivin inhibited growth factor deprivation - or ceramide - induced apoptosis, reduced caspase - 3 and - 7 generation, and stabilized three - dimensional capillary networks in vitro.	"Adenoviral	9	19	Organism"	"endothelial cells	36	53	Cell"	"pAd - Survivin	59	73	Gene_or_gene_product"	"ceramide	115	123	Chemical"	"caspase - 3	153	164	Gene_or_gene_product"	"- 7	169	172	Gene_or_gene_product"	"capillary networks	220	238	Multi"	"[{""token"": ""Adenoviral"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 36, ""end_span"": 53, ""type"": ""Cell""}, {""token"": ""pAd - Survivin"", ""start_span"": 59, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""ceramide"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""caspase - 3"", ""start_span"": 153, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 7"", ""start_span"": 169, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""capillary networks"", ""start_span"": 220, ""end_span"": 238, ""type"": ""Multi""}]"
Cytotoxic concentrations of cisplatin, etoposide, doxorubicin or peplomycin ( tentatively termed as Group I compounds), but not methotrexate and 5 - FU ( tentatively termed as Group II compounds), enhanced the cytotoxic activity of NaF.	"cisplatin	28	37	Chemical"	"etoposide	39	48	Chemical"	"doxorubicin	50	61	Chemical"	"peplomycin	65	75	Chemical"	"methotrexate	128	140	Chemical"	"5 - FU	145	151	Chemical"	"NaF	232	235	Chemical"	"[{""token"": ""cisplatin"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""etoposide"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""doxorubicin"", ""start_span"": 50, ""end_span"": 61, ""type"": ""Chemical""}, {""token"": ""peplomycin"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Chemical""}, {""token"": ""methotrexate"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Chemical""}, {""token"": ""NaF"", ""start_span"": 232, ""end_span"": 235, ""type"": ""Chemical""}]"
NaF reduced the glucose consumption at early stage, possibly by inhibition of glycolysis, whereas cisplatin and etoposide reduced the glucose consumption at later stage, suggesting that early decline of glucose consumption is rather specific to NaF.	"NaF	0	3	Chemical"	"glucose	16	23	Chemical"	"cisplatin	98	107	Chemical"	"etoposide	112	121	Chemical"	"glucose	134	141	Chemical"	"glucose	203	210	Chemical"	"NaF	245	248	Chemical"	"[{""token"": ""NaF"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 16, ""end_span"": 23, ""type"": ""Chemical""}, {""token"": ""cisplatin"", ""start_span"": 98, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""etoposide"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 134, ""end_span"": 141, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 203, ""end_span"": 210, ""type"": ""Chemical""}, {""token"": ""NaF"", ""start_span"": 245, ""end_span"": 248, ""type"": ""Chemical""}]"
This chapter focuses on the morphology of blood vessel formation in and around the early central nervous system ( CNS, i. e., brain and spinal cord) of avian embryos.	"blood vessel	42	54	Multi"	"central nervous system	89	111	Anatomical_system"	"CNS	114	117	Anatomical_system"	"brain	126	131	Organ"	"spinal cord	136	147	Organ"	"avian	152	157	Organism"	"embryos	158	165	Developing_anatomical_structure"	"[{""token"": ""blood vessel"", ""start_span"": 42, ""end_span"": 54, ""type"": ""Multi""}, {""token"": ""central nervous system"", ""start_span"": 89, ""end_span"": 111, ""type"": ""Anatomical_system""}, {""token"": ""CNS"", ""start_span"": 114, ""end_span"": 117, ""type"": ""Anatomical_system""}, {""token"": ""brain"", ""start_span"": 126, ""end_span"": 131, ""type"": ""Organ""}, {""token"": ""spinal cord"", ""start_span"": 136, ""end_span"": 147, ""type"": ""Organ""}, {""token"": ""avian"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Organism""}, {""token"": ""embryos"", ""start_span"": 158, ""end_span"": 165, ""type"": ""Developing_anatomical_structure""}]"
In mice, xenografts of human glioblastoma U87MG, which has decreased expression of ING4, grow significantly faster and have higher vascular volume fractions than control tumours.	"mice	3	7	Organism"	"xenografts	9	19	Cancer"	"human	23	28	Organism"	"glioblastoma U87MG	29	47	Cancer"	"ING4	83	87	Gene_or_gene_product"	"vascular	131	139	Multi"	"tumours	170	177	Cancer"	"[{""token"": ""mice"", ""start_span"": 3, ""end_span"": 7, ""type"": ""Organism""}, {""token"": ""xenografts"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""glioblastoma U87MG"", ""start_span"": 29, ""end_span"": 47, ""type"": ""Cancer""}, {""token"": ""ING4"", ""start_span"": 83, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 131, ""end_span"": 139, ""type"": ""Multi""}, {""token"": ""tumours"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Cancer""}]"
We show that ING4 physically interacts with p65 ( RelA) subunit of nuclear factor NF - kappaB, and that ING4 regulates brain tumour angiogenesis through transcriptional repression of NF - kappaB - responsive genes.	"ING4	13	17	Gene_or_gene_product"	"p65	44	47	Gene_or_gene_product"	"RelA	50	54	Gene_or_gene_product"	"NF - kappaB	82	93	Gene_or_gene_product"	"ING4	104	108	Gene_or_gene_product"	"brain tumour	119	131	Cancer"	"NF - kappaB	183	194	Gene_or_gene_product"	"[{""token"": ""ING4"", ""start_span"": 13, ""end_span"": 17, ""type"": ""Gene_or_gene_product""}, {""token"": ""p65"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""RelA"", ""start_span"": 50, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 82, ""end_span"": 93, ""type"": ""Gene_or_gene_product""}, {""token"": ""ING4"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""brain tumour"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Cancer""}, {""token"": ""NF - kappaB"", ""start_span"": 183, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"
With the discovery that TGFbeta1 was a potent growth inhibitor of epithelial cells, and the identification of inactivating mutations within the TGFbeta1 signaling pathway in cancers it became clear that TGFbeta1 signaling is a tumor suppressor pathway for early stages of cancer.	"TGFbeta1	24	32	Gene_or_gene_product"	"epithelial cells	66	82	Cell"	"TGFbeta1	144	152	Gene_or_gene_product"	"cancers	174	181	Cancer"	"TGFbeta1	203	211	Gene_or_gene_product"	"tumor	227	232	Cancer"	"cancer	272	278	Cancer"	"[{""token"": ""TGFbeta1"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial cells"", ""start_span"": 66, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""TGFbeta1"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancers"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Cancer""}, {""token"": ""TGFbeta1"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Cancer""}, {""token"": ""cancer"", ""start_span"": 272, ""end_span"": 278, ""type"": ""Cancer""}]"
In this study, to examine hypoxia - specific production of anti - angiogenic therapeutic gene, we constructed 5 copies of HRE ( 5xHRE) of human VEGF linked to soluble Tie2 ( sTie2) driven by minimal SV40 promoter ( 5xHRE / SV40 / sTie2).	"human	138	143	Organism"	"VEGF	144	148	Gene_or_gene_product"	"Tie2	167	171	Gene_or_gene_product"	"sTie2	174	179	Gene_or_gene_product"	"SV40	199	203	Gene_or_gene_product"	"SV40	223	227	Gene_or_gene_product"	"sTie2	230	235	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""VEGF"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Gene_or_gene_product""}, {""token"": ""Tie2"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 199, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 223, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""sTie2"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene_or_gene_product""}]"
Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer.	"Thalidomide	0	11	Chemical"	"angiostatin	16	27	Gene_or_gene_product"	"tumor	36	41	Cancer"	"murine	54	60	Organism"	"xenograft	61	70	Cancer"	"human	80	85	Organism"	"cervical cancer	86	101	Cancer"	"[{""token"": ""Thalidomide"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""angiostatin"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""murine"", ""start_span"": 54, ""end_span"": 60, ""type"": ""Organism""}, {""token"": ""xenograft"", ""start_span"": 61, ""end_span"": 70, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Organism""}, {""token"": ""cervical cancer"", ""start_span"": 86, ""end_span"": 101, ""type"": ""Cancer""}]"
HKa and D5 inhibit bovine pulmonary artery endothelial cell ( BPAE) or human umbilical vein endothelial cell chemotaxis in the modified - Boyden chamber in response toVEGF or S1P.	"HKa	0	3	Gene_or_gene_product"	"bovine	19	25	Organism"	"pulmonary artery endothelial cell	26	59	Cell"	"BPAE	62	66	Cell"	"human umbilical vein endothelial cell	71	108	Cell"	"toVEGF	165	171	Gene_or_gene_product"	"S1P	175	178	Gene_or_gene_product"	"[{""token"": ""HKa"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Organism""}, {""token"": ""pulmonary artery endothelial cell"", ""start_span"": 26, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""BPAE"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Cell""}, {""token"": ""human umbilical vein endothelial cell"", ""start_span"": 71, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""toVEGF"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""S1P"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Gene_or_gene_product""}]"
Inhibition of c - Jun amino - terminal kinase ( JNK) blocked type III collagen expression in LRP - 1 - deficient MEFs, suggesting regulation of JNK activity as a mechanism by which LRP - 1 controls mRNA expression.	"c - Jun amino - terminal kinase	14	45	Gene_or_gene_product"	"JNK	48	51	Gene_or_gene_product"	"type III collagen	61	78	Gene_or_gene_product"	"LRP - 1	93	100	Gene_or_gene_product"	"MEFs	113	117	Cell"	"JNK	144	147	Gene_or_gene_product"	"LRP - 1	181	188	Gene_or_gene_product"	"[{""token"": ""c - Jun amino - terminal kinase"", ""start_span"": 14, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""JNK"", ""start_span"": 48, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""type III collagen"", ""start_span"": 61, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 93, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""JNK"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""LRP - 1"", ""start_span"": 181, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}]"
Our results showed that MTX administration increased the MDA and MPO activities and collagen content and decreased GSH levels in all tissues, while these alterations were reversed in L - Car - treated group.	"MTX	24	27	Chemical"	"MDA	57	60	Chemical"	"MPO	65	68	Chemical"	"collagen	84	92	Gene_or_gene_product"	"GSH	115	118	Chemical"	"tissues	133	140	Tissue"	"L - Car	183	190	Chemical"	"[{""token"": ""MTX"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""MDA"", ""start_span"": 57, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""MPO"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical""}, {""token"": ""collagen"", ""start_span"": 84, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""GSH"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""tissues"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Tissue""}, {""token"": ""L - Car"", ""start_span"": 183, ""end_span"": 190, ""type"": ""Chemical""}]"
Severe degeneration of the intestinal mucosa, liver parenchyma, and glomerular and tubular epithelium observed in the saline - treated MTX group was improved by L - Car treatment.	"intestinal mucosa	27	44	Multi"	"liver parenchyma	46	62	Multi"	"glomerular	68	78	Tissue"	"tubular epithelium	83	101	Tissue"	"saline	118	124	Chemical"	"MTX	135	138	Chemical"	"L - Car	161	168	Chemical"	"[{""token"": ""intestinal mucosa"", ""start_span"": 27, ""end_span"": 44, ""type"": ""Multi""}, {""token"": ""liver parenchyma"", ""start_span"": 46, ""end_span"": 62, ""type"": ""Multi""}, {""token"": ""glomerular"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Tissue""}, {""token"": ""tubular epithelium"", ""start_span"": 83, ""end_span"": 101, ""type"": ""Tissue""}, {""token"": ""saline"", ""start_span"": 118, ""end_span"": 124, ""type"": ""Chemical""}, {""token"": ""MTX"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""L - Car"", ""start_span"": 161, ""end_span"": 168, ""type"": ""Chemical""}]"
Conversely, tumor cell expression of NCAM in a fibrosarcoma model ( T241) improved pericyte recruitment and increased perivascular deposition of ECM molecules.	"tumor cell	12	22	Cell"	"NCAM	37	41	Gene_or_gene_product"	"fibrosarcoma	47	59	Cancer"	"T241	68	72	Cancer"	"pericyte	83	91	Cell"	"perivascular	118	130	Immaterial_anatomical_entity"	"ECM molecules	145	158	Cellular_component"	"[{""token"": ""tumor cell"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Cell""}, {""token"": ""NCAM"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibrosarcoma"", ""start_span"": 47, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""T241"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Cancer""}, {""token"": ""pericyte"", ""start_span"": 83, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""perivascular"", ""start_span"": 118, ""end_span"": 130, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""ECM molecules"", ""start_span"": 145, ""end_span"": 158, ""type"": ""Cellular_component""}]"
Overall, paclitaxel exerts its anti - tumour effects on cervical cancer cells by inducing apoptosis through intrinsic pathway, and rapamycin targeted to mTOR can sensitise paclitaxel - resistant cervical cancer cells.	"paclitaxel	9	19	Chemical"	"tumour	38	44	Cancer"	"cervical cancer cells	56	77	Cell"	"rapamycin	131	140	Chemical"	"mTOR	153	157	Gene_or_gene_product"	"paclitaxel	172	182	Chemical"	"cervical cancer cells	195	216	Cell"	"[{""token"": ""paclitaxel"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Chemical""}, {""token"": ""tumour"", ""start_span"": 38, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""cervical cancer cells"", ""start_span"": 56, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""rapamycin"", ""start_span"": 131, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""mTOR"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""paclitaxel"", ""start_span"": 172, ""end_span"": 182, ""type"": ""Chemical""}, {""token"": ""cervical cancer cells"", ""start_span"": 195, ""end_span"": 216, ""type"": ""Cell""}]"
PCNSLs with HRK methylation also showed methylation of multiple genes, such as p14ARF, p16INK4a, RB1, p27Kip1 and O6 - MGMT.	"PCNSLs	0	6	Cancer"	"HRK	12	15	Gene_or_gene_product"	"p14ARF	79	85	Gene_or_gene_product"	"p16INK4a	87	95	Gene_or_gene_product"	"RB1	97	100	Gene_or_gene_product"	"p27Kip1	102	109	Gene_or_gene_product"	"O6 - MGMT	114	123	Gene_or_gene_product"	"[{""token"": ""PCNSLs"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Cancer""}, {""token"": ""HRK"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Gene_or_gene_product""}, {""token"": ""p14ARF"", ""start_span"": 79, ""end_span"": 85, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16INK4a"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene_or_gene_product""}, {""token"": ""RB1"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""p27Kip1"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""O6 - MGMT"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
In vitro studies using monolayer cultures of human tumor cell lines have shown that 2 - DG selectively inhibits energy - dependent DNA repair and cellular recovery processes in cancer cells.	"monolayer cultures	23	41	Cell"	"human	45	50	Organism"	"tumor cell lines	51	67	Cell"	"2 - DG	84	90	Chemical"	"DNA	131	134	Cellular_component"	"cellular	146	154	Cell"	"cancer cells	177	189	Cell"	"[{""token"": ""monolayer cultures"", ""start_span"": 23, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Organism""}, {""token"": ""tumor cell lines"", ""start_span"": 51, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""2 - DG"", ""start_span"": 84, ""end_span"": 90, ""type"": ""Chemical""}, {""token"": ""DNA"", ""start_span"": 131, ""end_span"": 134, ""type"": ""Cellular_component""}, {""token"": ""cellular"", ""start_span"": 146, ""end_span"": 154, ""type"": ""Cell""}, {""token"": ""cancer cells"", ""start_span"": 177, ""end_span"": 189, ""type"": ""Cell""}]"
The present study compares the radiomodification by 2 - DG in monolayer cultures and spheroids of a human glioma cell line ( BMG - 1) to gain insight into the effects in solid tumors.	"2 - DG	52	58	Chemical"	"monolayer cultures	62	80	Cell"	"spheroids	85	94	Cell"	"human	100	105	Organism"	"glioma cell line	106	122	Cell"	"BMG - 1	125	132	Cell"	"solid tumors	170	182	Cancer"	"[{""token"": ""2 - DG"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Chemical""}, {""token"": ""monolayer cultures"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Organism""}, {""token"": ""glioma cell line"", ""start_span"": 106, ""end_span"": 122, ""type"": ""Cell""}, {""token"": ""BMG - 1"", ""start_span"": 125, ""end_span"": 132, ""type"": ""Cell""}, {""token"": ""solid tumors"", ""start_span"": 170, ""end_span"": 182, ""type"": ""Cancer""}]"
Although the Bcl - 2 and Bax levels were significantly higher in spheroids, Bcl - 2 / Bax ratio was similar in monolayers and spheroids.	"Bcl - 2	13	20	Gene_or_gene_product"	"Bax	25	28	Gene_or_gene_product"	"spheroids	65	74	Cell"	"Bcl - 2	76	83	Gene_or_gene_product"	"Bax	86	89	Gene_or_gene_product"	"monolayers	111	121	Cell"	"spheroids	126	135	Cell"	"[{""token"": ""Bcl - 2"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Gene_or_gene_product""}, {""token"": ""spheroids"", ""start_span"": 65, ""end_span"": 74, ""type"": ""Cell""}, {""token"": ""Bcl - 2"", ""start_span"": 76, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""monolayers"", ""start_span"": 111, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""spheroids"", ""start_span"": 126, ""end_span"": 135, ""type"": ""Cell""}]"
The tree / fruit can be divided into several anatomical compartments: ( 1) seed, ( 2) juice, ( 3) peel, ( 4) leaf, ( 5) flower, ( 6) bark, and ( 7) roots, each of which has interesting pharmacologic activity.	"seed	75	79	Developing_anatomical_structure"	"juice	86	91	Organism_substance"	"peel	98	102	Tissue"	"leaf	109	113	Organ"	"flower	120	126	Organism_subdivision"	"bark	133	137	Tissue"	"roots	148	153	Organ"	"[{""token"": ""seed"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Developing_anatomical_structure""}, {""token"": ""juice"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism_substance""}, {""token"": ""peel"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Tissue""}, {""token"": ""leaf"", ""start_span"": 109, ""end_span"": 113, ""type"": ""Organ""}, {""token"": ""flower"", ""start_span"": 120, ""end_span"": 126, ""type"": ""Organism_subdivision""}, {""token"": ""bark"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Tissue""}, {""token"": ""roots"", ""start_span"": 148, ""end_span"": 153, ""type"": ""Organ""}]"
Here we show that recombinant human prothrombin kringle - 2 ( rk - 2) inhibited bovine capillary endothelial cell migration with an IC ( 50) ( concentration for half maximal inhibition) of 38 nM and inhibited adhesion to extracellular matrix ( ECM) proteins.	"human	30	35	Organism"	"prothrombin kringle - 2	36	59	Gene_or_gene_product"	"rk - 2	62	68	Gene_or_gene_product"	"bovine	80	86	Organism"	"capillary endothelial cell	87	113	Cell"	"extracellular matrix	221	241	Cellular_component"	"ECM	244	247	Cellular_component"	"[{""token"": ""human"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Organism""}, {""token"": ""prothrombin kringle - 2"", ""start_span"": 36, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""rk - 2"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 80, ""end_span"": 86, ""type"": ""Organism""}, {""token"": ""capillary endothelial cell"", ""start_span"": 87, ""end_span"": 113, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 221, ""end_span"": 241, ""type"": ""Cellular_component""}, {""token"": ""ECM"", ""start_span"": 244, ""end_span"": 247, ""type"": ""Cellular_component""}]"
In 32 evaluated breast cancer patients with endocrine - dependent distant metastases treated with a new immunotherapy schedule ( cyclic administration of beta - interferon and interleukin - 2), cellular immunity, cytokines and CRP were related to the clinical course.	"breast cancer	16	29	Cancer"	"patients	30	38	Organism"	"endocrine	44	53	Anatomical_system"	"beta - interferon	154	171	Gene_or_gene_product"	"interleukin - 2	176	191	Gene_or_gene_product"	"cellular	194	202	Cell"	"CRP	227	230	Gene_or_gene_product"	"[{""token"": ""breast cancer"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 30, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""endocrine"", ""start_span"": 44, ""end_span"": 53, ""type"": ""Anatomical_system""}, {""token"": ""beta - interferon"", ""start_span"": 154, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 2"", ""start_span"": 176, ""end_span"": 191, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Cell""}, {""token"": ""CRP"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}]"
The present study used JB6 P + mouse epidermal cells and AP - 1 - luciferase reporter transgenic mice to identify whether exposure to Cum - OOH caused activation of AP - 1, oxidative stress, depletion of antioxidants and tumor formation during two - stage carcinogenesis.	"mouse	31	36	Organism"	"AP - 1	57	63	Gene_or_gene_product"	"luciferase	66	76	Gene_or_gene_product"	"mice	97	101	Organism"	"Cum - OOH	134	143	Chemical"	"AP - 1	165	171	Gene_or_gene_product"	"tumor	221	226	Cancer"	"[{""token"": ""mouse"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Organism""}, {""token"": ""AP - 1"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Organism""}, {""token"": ""Cum - OOH"", ""start_span"": 134, ""end_span"": 143, ""type"": ""Chemical""}, {""token"": ""AP - 1"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 221, ""end_span"": 226, ""type"": ""Cancer""}]"
In vitro studies found that exposure to Cum - OOH reduced the level of glutathione ( GSH) in mouse epidermal cells ( JB6 P +) and caused the induction of AP - 1.	"Cum - OOH	40	49	Chemical"	"glutathione	71	82	Chemical"	"GSH	85	88	Chemical"	"mouse	93	98	Organism"	"epidermal cells	99	114	Cell"	"JB6 P +	117	124	Cell"	"AP - 1	154	160	Gene_or_gene_product"	"[{""token"": ""Cum - OOH"", ""start_span"": 40, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""glutathione"", ""start_span"": 71, ""end_span"": 82, ""type"": ""Chemical""}, {""token"": ""GSH"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Organism""}, {""token"": ""epidermal cells"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Cell""}, {""token"": ""JB6 P +"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""AP - 1"", ""start_span"": 154, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}]"
Vascular development is dependent on various growth factors and certain modifiers critical for providing arterial or venous identity, interaction with the surrounding stroma and tissues, hierarchic network formation, and recruitment of pericytes.	"Vascular	0	8	Multi"	"arterial	105	113	Multi"	"venous	117	123	Multi"	"stroma	167	173	Tissue"	"tissues	178	185	Tissue"	"hierarchic network	187	205	Tissue"	"pericytes	236	245	Cell"	"[{""token"": ""Vascular"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Multi""}, {""token"": ""arterial"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Multi""}, {""token"": ""venous"", ""start_span"": 117, ""end_span"": 123, ""type"": ""Multi""}, {""token"": ""stroma"", ""start_span"": 167, ""end_span"": 173, ""type"": ""Tissue""}, {""token"": ""tissues"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Tissue""}, {""token"": ""hierarchic network"", ""start_span"": 187, ""end_span"": 205, ""type"": ""Tissue""}, {""token"": ""pericytes"", ""start_span"": 236, ""end_span"": 245, ""type"": ""Cell""}]"
The role of SWAP - 70 in oncogenic transformation of mouse embryo fibroblasts ( MEFs) by v - Src was examined by use of MEFs defective in SWAP - 70.	"SWAP - 70	12	21	Gene_or_gene_product"	"mouse	53	58	Organism"	"embryo fibroblasts	59	77	Cell"	"MEFs	80	84	Cell"	"v - Src	89	96	Gene_or_gene_product"	"MEFs	120	124	Cell"	"SWAP - 70	138	147	Gene_or_gene_product"	"[{""token"": ""SWAP - 70"", ""start_span"": 12, ""end_span"": 21, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 59, ""end_span"": 77, ""type"": ""Cell""}, {""token"": ""MEFs"", ""start_span"": 80, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""v - Src"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEFs"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Cell""}, {""token"": ""SWAP - 70"", ""start_span"": 138, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}]"
In animal studies, 1B3 significantly enhanced the antitumor and the anti - angiogenic activities of DC101, an antibody directed against mouse vascular endothelial growth factor receptor 2, in a pancreatic ( BxPC - 3) and a non - small cell lung ( NCI - H460) tumor xenograft models.	"1B3	19	22	Chemical"	"antitumor	50	59	Cancer"	"DC101	100	105	Chemical"	"mouse	136	141	Organism"	"vascular endothelial growth factor receptor 2	142	187	Gene_or_gene_product"	"pancreatic	194	204	Cancer"	"BxPC - 3	207	215	Cancer"	"[{""token"": ""1B3"", ""start_span"": 19, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""antitumor"", ""start_span"": 50, ""end_span"": 59, ""type"": ""Cancer""}, {""token"": ""DC101"", ""start_span"": 100, ""end_span"": 105, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Organism""}, {""token"": ""vascular endothelial growth factor receptor 2"", ""start_span"": 142, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""pancreatic"", ""start_span"": 194, ""end_span"": 204, ""type"": ""Cancer""}, {""token"": ""BxPC - 3"", ""start_span"": 207, ""end_span"": 215, ""type"": ""Cancer""}]"
Caffeine inhibits adenosine - induced accumulation of hypoxia - inducible factor - 1alpha, vascular endothelial growth factor, and interleukin - 8 expression in hypoxic human colon cancer cells.	"Caffeine	0	8	Chemical"	"adenosine	18	27	Chemical"	"hypoxia - inducible factor - 1alpha	54	89	Gene_or_gene_product"	"vascular endothelial growth factor	91	125	Gene_or_gene_product"	"interleukin - 8	131	146	Gene_or_gene_product"	"human	169	174	Organism"	"colon cancer cells	175	193	Cell"	"[{""token"": ""Caffeine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical""}, {""token"": ""adenosine"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical""}, {""token"": ""hypoxia - inducible factor - 1alpha"", ""start_span"": 54, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 91, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 131, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Organism""}, {""token"": ""colon cancer cells"", ""start_span"": 175, ""end_span"": 193, ""type"": ""Cell""}]"
The induction of vascular endothelial growth factor ( VEGF) and interleukin - 8 ( IL - 8) is an essential feature of tumor angiogenesis, and the hypoxia - inducible factor - 1 ( HIF - 1) transcription factor is known to be a key regulator of this process.	"vascular endothelial growth factor	17	51	Gene_or_gene_product"	"VEGF	54	58	Gene_or_gene_product"	"interleukin - 8	64	79	Gene_or_gene_product"	"IL - 8	82	88	Gene_or_gene_product"	"tumor	117	122	Cancer"	"hypoxia - inducible factor - 1	145	175	Gene_or_gene_product"	"HIF - 1	178	185	Gene_or_gene_product"	"[{""token"": ""vascular endothelial growth factor"", ""start_span"": 17, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 64, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 117, ""end_span"": 122, ""type"": ""Cancer""}, {""token"": ""hypoxia - inducible factor - 1"", ""start_span"": 145, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""HIF - 1"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Gene_or_gene_product""}]"
These data provide evidence that adenosine could modulate the migration of colon cancer cells by an HIF - 1alpha / VEGF / IL - 8 - dependent mechanism and that caffeine has the potential to inhibit colon cancer cell growth.	"adenosine	33	42	Chemical"	"colon cancer cells	75	93	Cell"	"HIF - 1alpha	100	112	Gene_or_gene_product"	"VEGF	115	119	Gene_or_gene_product"	"IL - 8	122	128	Gene_or_gene_product"	"caffeine	160	168	Chemical"	"colon cancer cell	198	215	Cell"	"[{""token"": ""adenosine"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Chemical""}, {""token"": ""colon cancer cells"", ""start_span"": 75, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""HIF - 1alpha"", ""start_span"": 100, ""end_span"": 112, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 8"", ""start_span"": 122, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""caffeine"", ""start_span"": 160, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""colon cancer cell"", ""start_span"": 198, ""end_span"": 215, ""type"": ""Cell""}]"
BAG - 1L was nucleoplasmic and nucleolar, whereas BAG - 1S and BAG - 1M were cytoplasmic and nucleoplasmic in localisation.	"BAG - 1L	0	8	Gene_or_gene_product"	"nucleoplasmic	13	26	Organism_substance"	"nucleolar	31	40	Cellular_component"	"BAG - 1S	50	58	Gene_or_gene_product"	"BAG - 1M	63	71	Gene_or_gene_product"	"cytoplasmic	77	88	Organism_substance"	"nucleoplasmic	93	106	Organism_substance"	"[{""token"": ""BAG - 1L"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleoplasmic"", ""start_span"": 13, ""end_span"": 26, ""type"": ""Organism_substance""}, {""token"": ""nucleolar"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Cellular_component""}, {""token"": ""BAG - 1S"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1M"", ""start_span"": 63, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasmic"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Organism_substance""}, {""token"": ""nucleoplasmic"", ""start_span"": 93, ""end_span"": 106, ""type"": ""Organism_substance""}]"
BAG - 1L also potentiated transactivation of known vitamin - D - responsive gene promoters, osteocalcin and 24 - hydroxylase, and enhanced VDR - dependent transcription and protein expression of the keratinocyte differentiation marker, involucrin.	"BAG - 1L	0	8	Gene_or_gene_product"	"vitamin - D	51	62	Chemical"	"osteocalcin	92	103	Gene_or_gene_product"	"24 - hydroxylase	108	124	Gene_or_gene_product"	"VDR	139	142	Gene_or_gene_product"	"keratinocyte	199	211	Cell"	"involucrin	236	246	Gene_or_gene_product"	"[{""token"": ""BAG - 1L"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""vitamin - D"", ""start_span"": 51, ""end_span"": 62, ""type"": ""Chemical""}, {""token"": ""osteocalcin"", ""start_span"": 92, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""24 - hydroxylase"", ""start_span"": 108, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""VDR"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""keratinocyte"", ""start_span"": 199, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""involucrin"", ""start_span"": 236, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"
These results demonstrate endogenous gene regulation by BAG - 1L by potentiating nuclear hormone receptor function and suggest a role for BAG - 1L in 24 - hydroxylase regulation of vitamin D metabolism and the cellular response of oral keratinocytes to 1alpha, 25 - dihydroxyvitamin D3.	"BAG - 1L	56	64	Gene_or_gene_product"	"nuclear hormone receptor	81	105	Gene_or_gene_product"	"BAG - 1L	138	146	Gene_or_gene_product"	"24 - hydroxylase	150	166	Gene_or_gene_product"	"vitamin D	181	190	Chemical"	"cellular	210	218	Cell"	"oral keratinocytes	231	249	Cell"	"[{""token"": ""BAG - 1L"", ""start_span"": 56, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""nuclear hormone receptor"", ""start_span"": 81, ""end_span"": 105, ""type"": ""Gene_or_gene_product""}, {""token"": ""BAG - 1L"", ""start_span"": 138, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""24 - hydroxylase"", ""start_span"": 150, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""vitamin D"", ""start_span"": 181, ""end_span"": 190, ""type"": ""Chemical""}, {""token"": ""cellular"", ""start_span"": 210, ""end_span"": 218, ""type"": ""Cell""}, {""token"": ""oral keratinocytes"", ""start_span"": 231, ""end_span"": 249, ""type"": ""Cell""}]"
The steady - state extraction ratio of enalapril, a substrate that enters the liver rapidly via Oatp1a1 and primarily undergoes metabolism by the carboxylesterases, was unaffected by liver metastasis at week 4 regardless of its delivery via the portal vein or hepatic artery into the perfused liver preparations.	"enalapril	39	48	Chemical"	"liver	78	83	Organ"	"Oatp1a1	96	103	Gene_or_gene_product"	"liver	183	188	Organ"	"portal vein	245	256	Multi"	"hepatic artery	260	274	Multi"	"liver	293	298	Organ"	"[{""token"": ""enalapril"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical""}, {""token"": ""liver"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Organ""}, {""token"": ""Oatp1a1"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""liver"", ""start_span"": 183, ""end_span"": 188, ""type"": ""Organ""}, {""token"": ""portal vein"", ""start_span"": 245, ""end_span"": 256, ""type"": ""Multi""}, {""token"": ""hepatic artery"", ""start_span"": 260, ""end_span"": 274, ""type"": ""Multi""}, {""token"": ""liver"", ""start_span"": 293, ""end_span"": 298, ""type"": ""Organ""}]"
Recent studies using avian retrovirus - mediated introduction of oncogenes into a small subset of somatic mammary cells suggest that polyoma middle T antigen ( PyMT) may also preferentially transform stem / progenitor cells.	"avian retrovirus	21	37	Organism"	"somatic mammary cells	98	119	Cell"	"polyoma	133	140	Organism"	"middle T antigen	141	157	Gene_or_gene_product"	"PyMT	160	164	Gene_or_gene_product"	"stem	200	204	Cell"	"progenitor cells	207	223	Cell"	"[{""token"": ""avian retrovirus"", ""start_span"": 21, ""end_span"": 37, ""type"": ""Organism""}, {""token"": ""somatic mammary cells"", ""start_span"": 98, ""end_span"": 119, ""type"": ""Cell""}, {""token"": ""polyoma"", ""start_span"": 133, ""end_span"": 140, ""type"": ""Organism""}, {""token"": ""middle T antigen"", ""start_span"": 141, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""PyMT"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""stem"", ""start_span"": 200, ""end_span"": 204, ""type"": ""Cell""}, {""token"": ""progenitor cells"", ""start_span"": 207, ""end_span"": 223, ""type"": ""Cell""}]"
These data demonstrate for the first time that hCAP - 18 / LL - 37 is significantly overexpressed in ovarian tumors and suggest LL - 37 may contribute to ovarian tumorigenesis through direct stimulation of tumor cells, initiation of angiogenesis and recruitment of immune cells.	"hCAP - 18	47	56	Gene_or_gene_product"	"LL - 37	59	66	Gene_or_gene_product"	"ovarian tumors	101	115	Cancer"	"LL - 37	128	135	Gene_or_gene_product"	"ovarian	154	161	Organ"	"tumor cells	206	217	Cell"	"immune cells	265	277	Cell"	"[{""token"": ""hCAP - 18"", ""start_span"": 47, ""end_span"": 56, ""type"": ""Gene_or_gene_product""}, {""token"": ""LL - 37"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian tumors"", ""start_span"": 101, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""LL - 37"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Organ""}, {""token"": ""tumor cells"", ""start_span"": 206, ""end_span"": 217, ""type"": ""Cell""}, {""token"": ""immune cells"", ""start_span"": 265, ""end_span"": 277, ""type"": ""Cell""}]"
RESULTS: Mice bearing subcutaneous tumor of rAAV2 / 5 - VAS pretreated Lewis lung carcinoma cells showed > 50% reduction in primary tumor volume and reduced spontaneous pulmonary metastases.	"Mice	9	13	Organism"	"subcutaneous tumor	22	40	Cancer"	"rAAV2	44	49	Organism"	"5 - VAS	52	59	Organism"	"Lewis lung carcinoma cells	71	97	Cell"	"tumor	132	137	Cancer"	"pulmonary	169	178	Organ"	"[{""token"": ""Mice"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""subcutaneous tumor"", ""start_span"": 22, ""end_span"": 40, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Organism""}, {""token"": ""Lewis lung carcinoma cells"", ""start_span"": 71, ""end_span"": 97, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 132, ""end_span"": 137, ""type"": ""Cancer""}, {""token"": ""pulmonary"", ""start_span"": 169, ""end_span"": 178, ""type"": ""Organ""}]"
The tumor - suppressive action of rAAV2 / 5 - VAS in subcutaneous human lung tumor A549 xenograft correlated with a reduced number of capillary vessels in tumors.	"tumor	4	9	Cancer"	"rAAV2	34	39	Organism"	"5 - VAS	42	49	Organism"	"human	66	71	Organism"	"lung tumor A549 xenograft	72	97	Cancer"	"capillary vessels	134	151	Tissue"	"tumors	155	161	Cancer"	"[{""token"": ""tumor"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 42, ""end_span"": 49, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Organism""}, {""token"": ""lung tumor A549 xenograft"", ""start_span"": 72, ""end_span"": 97, ""type"": ""Cancer""}, {""token"": ""capillary vessels"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Tissue""}, {""token"": ""tumors"", ""start_span"": 155, ""end_span"": 161, ""type"": ""Cancer""}]"
CONCLUSION: Our results show the effectiveness of rAAV2 / 5 - VAS as an angiogenesis inhibitor in suppressing tumor growth during different stages of tumor progression, validating the application of rAAV2 / 5 - VAS gene therapy in treatment against lung cancer.	"rAAV2	50	55	Organism"	"5 - VAS	58	65	Organism"	"tumor	110	115	Cancer"	"tumor	150	155	Cancer"	"rAAV2	199	204	Organism"	"5 - VAS	207	214	Organism"	"lung cancer	249	260	Cancer"	"[{""token"": ""rAAV2"", ""start_span"": 50, ""end_span"": 55, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Cancer""}, {""token"": ""tumor"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Cancer""}, {""token"": ""rAAV2"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Organism""}, {""token"": ""5 - VAS"", ""start_span"": 207, ""end_span"": 214, ""type"": ""Organism""}, {""token"": ""lung cancer"", ""start_span"": 249, ""end_span"": 260, ""type"": ""Cancer""}]"
We tested this using HT - 1080, NCI, and Shac fibrosarcoma - derived cell lines and anthrax lethal toxin ( LeTx), a bacterial toxin that inactivates MKKs.	"HT - 1080	21	30	Cell"	"NCI	32	35	Cell"	"Shac fibrosarcoma - derived cell lines	41	79	Cell"	"anthrax	84	91	Organism"	"lethal toxin	92	104	Chemical"	"LeTx	107	111	Chemical"	"MKKs	149	153	Gene_or_gene_product"	"[{""token"": ""HT - 1080"", ""start_span"": 21, ""end_span"": 30, ""type"": ""Cell""}, {""token"": ""NCI"", ""start_span"": 32, ""end_span"": 35, ""type"": ""Cell""}, {""token"": ""Shac fibrosarcoma - derived cell lines"", ""start_span"": 41, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""anthrax"", ""start_span"": 84, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""lethal toxin"", ""start_span"": 92, ""end_span"": 104, ""type"": ""Chemical""}, {""token"": ""LeTx"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Chemical""}, {""token"": ""MKKs"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}]"
These cells were negative for Hep par - 1, carcinoembryonic antigen, neural cell adhesion molecule, CD34, CD31 and HMB45.	"cells	6	11	Cell"	"Hep par - 1	30	41	Gene_or_gene_product"	"carcinoembryonic antigen	43	67	Gene_or_gene_product"	"neural cell adhesion molecule	69	98	Gene_or_gene_product"	"CD34	100	104	Gene_or_gene_product"	"CD31	106	110	Gene_or_gene_product"	"HMB45	115	120	Gene_or_gene_product"	"[{""token"": ""cells"", ""start_span"": 6, ""end_span"": 11, ""type"": ""Cell""}, {""token"": ""Hep par - 1"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""carcinoembryonic antigen"", ""start_span"": 43, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""neural cell adhesion molecule"", ""start_span"": 69, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD34"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD31"", ""start_span"": 106, ""end_span"": 110, ""type"": ""Gene_or_gene_product""}, {""token"": ""HMB45"", ""start_span"": 115, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}]"
METHOD: Wild - type and phosphatase - inactive ( C124A) PTEN plasmids were transfected into ovarian epithelial cancer A2780 cells, and their effects on cell apoptosis, cell proliferation, cell migration and cell invasion were analyzed by flow cytometry analysis, TUNEL assay, MTT assay, wound - healing assay and transwell assay.	"PTEN	56	60	Gene_or_gene_product"	"ovarian epithelial cancer A2780 cells	92	129	Cell"	"cell	152	156	Cell"	"cell	168	172	Cell"	"cell	188	192	Cell"	"cell	207	211	Cell"	"wound	287	292	Pathological_formation"	"[{""token"": ""PTEN"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""ovarian epithelial cancer A2780 cells"", ""start_span"": 92, ""end_span"": 129, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""wound"", ""start_span"": 287, ""end_span"": 292, ""type"": ""Pathological_formation""}]"
RESULTS: Both wild - type and mutant PTEN can upregulate the expression of PTEN gene dramatically; however, it is wild - type PTEN not phosphatase - inactive PTEN that can induce apoptosis and decrease cell migration, invasion and proliferation in ovarian cancer cells.	"PTEN	37	41	Gene_or_gene_product"	"PTEN	75	79	Gene_or_gene_product"	"PTEN	126	130	Gene_or_gene_product"	"phosphatase	135	146	Chemical"	"PTEN	158	162	Gene_or_gene_product"	"cell	202	206	Cell"	"ovarian cancer cells	248	268	Cell"	"[{""token"": ""PTEN"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatase"", ""start_span"": 135, ""end_span"": 146, ""type"": ""Chemical""}, {""token"": ""PTEN"", ""start_span"": 158, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 202, ""end_span"": 206, ""type"": ""Cell""}, {""token"": ""ovarian cancer cells"", ""start_span"": 248, ""end_span"": 268, ""type"": ""Cell""}]"
Three weeks after injection, blood perfusion and capillary density were significantly higher in the FM - MSC and BM - MSC groups than in the phosphate - buffered saline group, and allogeneic FM - MSC and BM - MSC were still observed.	"blood	29	34	Organism_substance"	"capillary	49	58	Tissue"	"FM - MSC	100	108	Cell"	"BM - MSC	113	121	Cell"	"phosphate - buffered saline	141	168	Chemical"	"FM - MSC	191	199	Cell"	"BM - MSC	204	212	Cell"	"[{""token"": ""blood"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Organism_substance""}, {""token"": ""capillary"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Tissue""}, {""token"": ""FM - MSC"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 113, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""phosphate - buffered saline"", ""start_span"": 141, ""end_span"": 168, ""type"": ""Chemical""}, {""token"": ""FM - MSC"", ""start_span"": 191, ""end_span"": 199, ""type"": ""Cell""}, {""token"": ""BM - MSC"", ""start_span"": 204, ""end_span"": 212, ""type"": ""Cell""}]"
RESEARCH DESIGN AND METHODS: Adipose tissue samples from visceral ( VAT) and subcutaneous ( SAT) sites, obtained from 36 obese patients ( mean BMI 46. 5 kg / m ( 2)) during bariatric surgery, were layered on chick chorioallantoic membrane ( CAM).	"Adipose tissue samples	29	51	Tissue"	"visceral	57	65	Tissue"	"VAT	68	71	Tissue"	"patients	127	135	Organism"	"chick	208	213	Organism"	"chorioallantoic membrane	214	238	Multi"	"CAM	241	244	Multi"	"[{""token"": ""Adipose tissue samples"", ""start_span"": 29, ""end_span"": 51, ""type"": ""Tissue""}, {""token"": ""visceral"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Tissue""}, {""token"": ""VAT"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Tissue""}, {""token"": ""patients"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Organism""}, {""token"": ""chick"", ""start_span"": 208, ""end_span"": 213, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 214, ""end_span"": 238, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 241, ""end_span"": 244, ""type"": ""Multi""}]"
The angiogenic potency of adipose tissue was not related to its localization ( with an angiogenic stimulation in 60% of SAT samples and 61% of VAT samples) or to adipocyte size or inflammatory infiltrate assessed in adipose samples before the graft on CAM.	"adipose tissue	26	40	Tissue"	"SAT samples	120	131	Tissue"	"VAT samples	143	154	Tissue"	"adipocyte	162	171	Cell"	"adipose samples	216	231	Tissue"	"graft	243	248	Tissue"	"CAM	252	255	Multi"	"[{""token"": ""adipose tissue"", ""start_span"": 26, ""end_span"": 40, ""type"": ""Tissue""}, {""token"": ""SAT samples"", ""start_span"": 120, ""end_span"": 131, ""type"": ""Tissue""}, {""token"": ""VAT samples"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Tissue""}, {""token"": ""adipocyte"", ""start_span"": 162, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""adipose samples"", ""start_span"": 216, ""end_span"": 231, ""type"": ""Tissue""}, {""token"": ""graft"", ""start_span"": 243, ""end_span"": 248, ""type"": ""Tissue""}, {""token"": ""CAM"", ""start_span"": 252, ""end_span"": 255, ""type"": ""Multi""}]"
Finally, mutating the Sp1 binding sites within the VEGF promoter or inhibiting ERK decreased VEGF promoter activity in M - CSF - treated human monocytes.	"Sp1	22	25	Gene_or_gene_product"	"VEGF	51	55	Gene_or_gene_product"	"ERK	79	82	Gene_or_gene_product"	"VEGF	93	97	Gene_or_gene_product"	"M - CSF	119	126	Gene_or_gene_product"	"human	137	142	Organism"	"monocytes	143	152	Cell"	"[{""token"": ""Sp1"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 93, ""end_span"": 97, ""type"": ""Gene_or_gene_product""}, {""token"": ""M - CSF"", ""start_span"": 119, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 137, ""end_span"": 142, ""type"": ""Organism""}, {""token"": ""monocytes"", ""start_span"": 143, ""end_span"": 152, ""type"": ""Cell""}]"
In this study, we investigated whether the nuclear transcription factor NF - kappaB, implicated in PC metastasis, is involved in transcriptional regulation and activation of BMP - 2 or BMP - 4 / Smad signaling in PC cells.	"nuclear	43	50	Cellular_component"	"NF - kappaB	72	83	Gene_or_gene_product"	"PC	99	101	Cancer"	"BMP - 2	174	181	Gene_or_gene_product"	"BMP - 4	185	192	Gene_or_gene_product"	"Smad	195	199	Gene_or_gene_product"	"PC cells	213	221	Cell"	"[{""token"": ""nuclear"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Cellular_component""}, {""token"": ""NF - kappaB"", ""start_span"": 72, ""end_span"": 83, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC"", ""start_span"": 99, ""end_span"": 101, ""type"": ""Cancer""}, {""token"": ""BMP - 2"", ""start_span"": 174, ""end_span"": 181, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 4"", ""start_span"": 185, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 195, ""end_span"": 199, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC cells"", ""start_span"": 213, ""end_span"": 221, ""type"": ""Cell""}]"
RESULTS: PCR and chimeric BMP - 2 and BMP - 4 luciferase assays demonstrate that NF - kappaB confers robust and selective activation of BMP - 2 in p65 overexpressing or rhTNF - alpha - stimulated PC cells.	"BMP - 2	26	33	Gene_or_gene_product"	"BMP - 4	38	45	Gene_or_gene_product"	"NF - kappaB	81	92	Gene_or_gene_product"	"BMP - 2	136	143	Gene_or_gene_product"	"p65	147	150	Gene_or_gene_product"	"rhTNF - alpha	169	182	Gene_or_gene_product"	"PC cells	196	204	Cell"	"[{""token"": ""BMP - 2"", ""start_span"": 26, ""end_span"": 33, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 4"", ""start_span"": 38, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 81, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 136, ""end_span"": 143, ""type"": ""Gene_or_gene_product""}, {""token"": ""p65"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""rhTNF - alpha"", ""start_span"": 169, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC cells"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Cell""}]"
Furthermore, suppression of NF - kappaB activation decreased the transcript levels and BMP - 2 - induced phosphorylation of Smad1 / 5 / 8, critical downstream targets of BMP - 2 signaling in PC cells.	"NF - kappaB	28	39	Gene_or_gene_product"	"BMP - 2	87	94	Gene_or_gene_product"	"Smad1	124	129	Gene_or_gene_product"	"5	132	133	Gene_or_gene_product"	"8	136	137	Gene_or_gene_product"	"BMP - 2	170	177	Gene_or_gene_product"	"PC cells	191	199	Cell"	"[{""token"": ""NF - kappaB"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad1"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Gene_or_gene_product""}, {""token"": ""5"", ""start_span"": 132, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""8"", ""start_span"": 136, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""BMP - 2"", ""start_span"": 170, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC cells"", ""start_span"": 191, ""end_span"": 199, ""type"": ""Cell""}]"
CONCLUSIONS: The data suggest that PI3K / Akt - NF - kappaB axis may promote PC bone metastasis in part by regulating transcription and activation of the BMP - 2 - Smad signaling cascade in osteotropic PC cells.	"PI3K	35	39	Gene_or_gene_product"	"Akt	42	45	Gene_or_gene_product"	"NF - kappaB	48	59	Gene_or_gene_product"	"PC bone	77	84	Multi"	"BMP - 2	154	161	Gene_or_gene_product"	"Smad	164	168	Gene_or_gene_product"	"osteotropic PC cells	190	210	Cell"	"[{""token"": ""PI3K"", ""start_span"": 35, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""NF - kappaB"", ""start_span"": 48, ""end_span"": 59, ""type"": ""Gene_or_gene_product""}, {""token"": ""PC bone"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Multi""}, {""token"": ""BMP - 2"", ""start_span"": 154, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""Smad"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene_or_gene_product""}, {""token"": ""osteotropic PC cells"", ""start_span"": 190, ""end_span"": 210, ""type"": ""Cell""}]"
Outcomes measures included transcutaneous blood gas levels, histology, total RNA content and analysis of alpha2 ( I) collagen ( COL - I), type IV collagen ( COL - IV), alpha1 ( V) collagen ( COL - V), and vascular endothelial growth factor ( VEGF) expression using real - time quantitative PCR.	"blood	42	47	Organism_substance"	"COL - I	128	135	Gene_or_gene_product"	"type IV collagen	138	154	Gene_or_gene_product"	"COL - IV	157	165	Gene_or_gene_product"	"COL - V	191	198	Gene_or_gene_product"	"vascular endothelial growth factor	205	239	Gene_or_gene_product"	"VEGF	242	246	Gene_or_gene_product"	"[{""token"": ""blood"", ""start_span"": 42, ""end_span"": 47, ""type"": ""Organism_substance""}, {""token"": ""COL - I"", ""start_span"": 128, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""type IV collagen"", ""start_span"": 138, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - IV"", ""start_span"": 157, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""COL - V"", ""start_span"": 191, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 205, ""end_span"": 239, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 242, ""end_span"": 246, ""type"": ""Gene_or_gene_product""}]"
OBJECTIVES: Strategies to inhibit the VEGF pathway, including antibodies to VEGF, antibodies to the extracellular domain of VEGFR - 1 or VEGFR - 2, decoy receptors for VEGF and tyrosine kinase inhibitors of VEGFRs, are summarized.	"VEGF	38	42	Gene_or_gene_product"	"antibodies to VEGF	62	80	Gene_or_gene_product"	"antibodies to the extracellular domain of VEGFR - 1	82	133	Gene_or_gene_product"	"VEGFR - 2	137	146	Gene_or_gene_product"	"VEGF	168	172	Gene_or_gene_product"	"tyrosine kinase inhibitors	177	203	Chemical"	"VEGFRs	207	213	Gene_or_gene_product"	"[{""token"": ""VEGF"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""antibodies to VEGF"", ""start_span"": 62, ""end_span"": 80, ""type"": ""Gene_or_gene_product""}, {""token"": ""antibodies to the extracellular domain of VEGFR - 1"", ""start_span"": 82, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""tyrosine kinase inhibitors"", ""start_span"": 177, ""end_span"": 203, ""type"": ""Chemical""}, {""token"": ""VEGFRs"", ""start_span"": 207, ""end_span"": 213, ""type"": ""Gene_or_gene_product""}]"
Oxygent perfusion medium increased the TET epithelial PtO ( 2) ( 51. 2 + / - 0. 3 mm Hg vs. 33. 4 + / - 0. 3 mm Hg at 200 microm thickness; 12. 5 + / - 0. 1 mm Hg vs. 3. 1 + / - 0. 1 mm Hg at 400 microm thickness, p less than 0. 01) and decreased the lactate concentration ( 0. 63 + / - 0. 08 vs. 0. 80 + / - 0. 06 mmol / L, p less than 0. 05), lactate / pyruvate ( 1. 87 + / - 0. 26 vs. 3. 36 + / - 10. 13, p less than 0. 05), and lactate / glucose ratios ( 0. 10 + / - 0. 00 vs. 0. 29 + / - 0. 14, p less than 0. 05).	"Oxygent	0	7	Chemical"	"TET epithelial	39	53	Tissue"	"lactate	251	258	Chemical"	"lactate	345	352	Chemical"	"pyruvate	355	363	Chemical"	"lactate	432	439	Chemical"	"glucose	442	449	Chemical"	"[{""token"": ""Oxygent"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical""}, {""token"": ""TET epithelial"", ""start_span"": 39, ""end_span"": 53, ""type"": ""Tissue""}, {""token"": ""lactate"", ""start_span"": 251, ""end_span"": 258, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 345, ""end_span"": 352, ""type"": ""Chemical""}, {""token"": ""pyruvate"", ""start_span"": 355, ""end_span"": 363, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 432, ""end_span"": 439, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 442, ""end_span"": 449, ""type"": ""Chemical""}]"
Semaphorins and their cognate receptors, Plexins and neuropilins, are involved in neuronal pathfinding, immune function, and tumor progression through effects on blood vessel growth and cell migration.	"Semaphorins	0	11	Gene_or_gene_product"	"Plexins	41	48	Gene_or_gene_product"	"neuropilins	53	64	Gene_or_gene_product"	"neuronal	82	90	Cell"	"tumor	125	130	Cancer"	"blood vessel	162	174	Multi"	"cell	186	190	Cell"	"[{""token"": ""Semaphorins"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Gene_or_gene_product""}, {""token"": ""Plexins"", ""start_span"": 41, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuropilins"", ""start_span"": 53, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""neuronal"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Cancer""}, {""token"": ""blood vessel"", ""start_span"": 162, ""end_span"": 174, ""type"": ""Multi""}, {""token"": ""cell"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Cell""}]"
Here we investigated this possibility by examining the role of FOXO3a in the cellular response to nicotine - derived nitrosaminoketone ( NNK), a lung carcinogen implicated as a cause of human LAC.	"FOXO3a	63	69	Gene_or_gene_product"	"cellular	77	85	Cell"	"nicotine - derived nitrosaminoketone	98	134	Chemical"	"NNK	137	140	Chemical"	"lung	145	149	Organ"	"human	186	191	Organism"	"LAC	192	195	Cancer"	"[{""token"": ""FOXO3a"", ""start_span"": 63, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 77, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""nicotine - derived nitrosaminoketone"", ""start_span"": 98, ""end_span"": 134, ""type"": ""Chemical""}, {""token"": ""NNK"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Chemical""}, {""token"": ""lung"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Organ""}, {""token"": ""human"", ""start_span"": 186, ""end_span"": 191, ""type"": ""Organism""}, {""token"": ""LAC"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Cancer""}]"
The more pronounced effects of Bmi - 1 over - expression in culture were largely attributable to the attenuated induction of p16 ( Ink4a) and p19 ( Arf) in culture, proteins that are generally not expressed by neural stem / progenitor cells in young mice in vivo.	"Bmi - 1	31	38	Gene_or_gene_product"	"p16	125	128	Gene_or_gene_product"	"Ink4a	131	136	Gene_or_gene_product"	"p19	142	145	Gene_or_gene_product"	"Arf	148	151	Gene_or_gene_product"	"neural stem / progenitor cells	210	240	Cell"	"mice	250	254	Organism"	"[{""token"": ""Bmi - 1"", ""start_span"": 31, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""p16"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Gene_or_gene_product""}, {""token"": ""p19"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""neural stem / progenitor cells"", ""start_span"": 210, ""end_span"": 240, ""type"": ""Cell""}, {""token"": ""mice"", ""start_span"": 250, ""end_span"": 254, ""type"": ""Organism""}]"
Since Akt phosphorylates Chk1 - Ser ( 280), the effect of Erbb2 on phosphatidyl inositol - 3 - kinase ( PI3K) / Akt signaling during UV - induced cell cycle arrest was determined.	"Akt	6	9	Gene_or_gene_product"	"Chk1	25	29	Gene_or_gene_product"	"Erbb2	58	63	Gene_or_gene_product"	"phosphatidyl inositol - 3 - kinase	67	101	Gene_or_gene_product"	"PI3K	104	108	Gene_or_gene_product"	"Akt	112	115	Gene_or_gene_product"	"cell	146	150	Cell"	"[{""token"": ""Akt"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Gene_or_gene_product""}, {""token"": ""Chk1"", ""start_span"": 25, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""Erbb2"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Gene_or_gene_product""}, {""token"": ""phosphatidyl inositol - 3 - kinase"", ""start_span"": 67, ""end_span"": 101, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Cell""}]"
We have shown that Arf6 and its effector AMAP1 ( DDEF1, DEF1, ASAP1 and centaurin beta4) are abnormally overexpressed in some breast cancers and used for their invasion and metastasis.	"Arf6	19	23	Gene_or_gene_product"	"AMAP1	41	46	Gene_or_gene_product"	"DDEF1	49	54	Gene_or_gene_product"	"DEF1	56	60	Gene_or_gene_product"	"ASAP1	62	67	Gene_or_gene_product"	"centaurin beta4	72	87	Gene_or_gene_product"	"breast cancers	126	140	Cancer"	"[{""token"": ""Arf6"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""AMAP1"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""DDEF1"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Gene_or_gene_product""}, {""token"": ""DEF1"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene_or_gene_product""}, {""token"": ""ASAP1"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Gene_or_gene_product""}, {""token"": ""centaurin beta4"", ""start_span"": 72, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""breast cancers"", ""start_span"": 126, ""end_span"": 140, ""type"": ""Cancer""}]"
Activated platelets enhance SKOV3 human ovarian cancer cell invasion through Matrigel and increase the amount of uPA and VEGF secreted into SKOV3 cell conditioned medium.	"platelets	10	19	Cell"	"SKOV3	28	33	Cell"	"human	34	39	Organism"	"ovarian cancer cell	40	59	Cell"	"uPA	113	116	Gene_or_gene_product"	"VEGF	121	125	Gene_or_gene_product"	"SKOV3 cell	140	150	Cell"	"[{""token"": ""platelets"", ""start_span"": 10, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""SKOV3"", ""start_span"": 28, ""end_span"": 33, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 34, ""end_span"": 39, ""type"": ""Organism""}, {""token"": ""ovarian cancer cell"", ""start_span"": 40, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene_or_gene_product""}, {""token"": ""SKOV3 cell"", ""start_span"": 140, ""end_span"": 150, ""type"": ""Cell""}]"
In addition, filopodia formation, a feature of motile cells, was inhibited in PECAM - 1 - null endothelial cells as well as in human endothelial cells treated with either anti - PECAM - 1 antibody or PECAM - 1 siRNA.	"filopodia	13	22	Cellular_component"	"cells	54	59	Cell"	"PECAM - 1	78	87	Gene_or_gene_product"	"human	127	132	Organism"	"endothelial cells	133	150	Cell"	"anti - PECAM - 1 antibody	171	196	Gene_or_gene_product"	"PECAM - 1	200	209	Gene_or_gene_product"	"[{""token"": ""filopodia"", ""start_span"": 13, ""end_span"": 22, ""type"": ""Cellular_component""}, {""token"": ""cells"", ""start_span"": 54, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""PECAM - 1"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 127, ""end_span"": 132, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 133, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""anti - PECAM - 1 antibody"", ""start_span"": 171, ""end_span"": 196, ""type"": ""Gene_or_gene_product""}, {""token"": ""PECAM - 1"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Gene_or_gene_product""}]"
The expression of metallothionein - 1 ( Mt - 1) gene, which is regulated by GR, was induced significantly by the combination of DMI and FA, and enhanced significantly by pretreatment with FA but not DMI.	"metallothionein - 1	18	37	Gene_or_gene_product"	"Mt - 1	40	46	Gene_or_gene_product"	"GR	76	78	Gene_or_gene_product"	"DMI	128	131	Chemical"	"FA	136	138	Chemical"	"FA	188	190	Chemical"	"DMI	199	202	Chemical"	"[{""token"": ""metallothionein - 1"", ""start_span"": 18, ""end_span"": 37, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mt - 1"", ""start_span"": 40, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""GR"", ""start_span"": 76, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""DMI"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Chemical""}, {""token"": ""FA"", ""start_span"": 188, ""end_span"": 190, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 199, ""end_span"": 202, ""type"": ""Chemical""}]"
On the basis of earlier findings that ERK5 deficiency in mouse EC results in massive defects in vessel architecture, we focused on the impact of the MEK5 / ERK5 signaling pathway on EC migration.	"ERK5	38	42	Gene_or_gene_product"	"mouse	57	62	Organism"	"EC	63	65	Cell"	"vessel architecture	96	115	Multi"	"MEK5	149	153	Gene_or_gene_product"	"ERK5	156	160	Gene_or_gene_product"	"EC	182	184	Cell"	"[{""token"": ""ERK5"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 57, ""end_span"": 62, ""type"": ""Organism""}, {""token"": ""EC"", ""start_span"": 63, ""end_span"": 65, ""type"": ""Cell""}, {""token"": ""vessel architecture"", ""start_span"": 96, ""end_span"": 115, ""type"": ""Multi""}, {""token"": ""MEK5"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK5"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 182, ""end_span"": 184, ""type"": ""Cell""}]"
In vitro cell proliferation, combination studies and vascular endothelial growth factor ( VEGF) secretion analyses were performed on endothelial ( HMVEC - d) and colorectal cancer ( HT - 29) cells exposed for 144 h to metronomic concentrations of SN - 38, the active metabolite of CPT - 11, L - OHP and 5 - FU.	"cell	9	13	Cell"	"vascular endothelial growth factor	53	87	Gene_or_gene_product"	"VEGF	90	94	Gene_or_gene_product"	"SN - 38	247	254	Chemical"	"CPT - 11	281	289	Chemical"	"L - OHP	291	298	Chemical"	"5 - FU	303	309	Chemical"	"[{""token"": ""cell"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 53, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""SN - 38"", ""start_span"": 247, ""end_span"": 254, ""type"": ""Chemical""}, {""token"": ""CPT - 11"", ""start_span"": 281, ""end_span"": 289, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 291, ""end_span"": 298, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 303, ""end_span"": 309, ""type"": ""Chemical""}]"
The beneficial effect of IL - 1Ra on most islet endothelial / OS / immune cells / fibrosis parameters analyzed highlights a major endothelial - related role for IL - 1 in GK islet alterations.	"IL - 1Ra	25	33	Chemical"	"islet endothelial	42	59	Cell"	"immune cells	67	79	Cell"	"endothelial	130	141	Cell"	"IL - 1	161	167	Gene_or_gene_product"	"GK	171	173	Organism"	"islet	174	179	Multi"	"[{""token"": ""IL - 1Ra"", ""start_span"": 25, ""end_span"": 33, ""type"": ""Chemical""}, {""token"": ""islet endothelial"", ""start_span"": 42, ""end_span"": 59, ""type"": ""Cell""}, {""token"": ""immune cells"", ""start_span"": 67, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""endothelial"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Cell""}, {""token"": ""IL - 1"", ""start_span"": 161, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""GK"", ""start_span"": 171, ""end_span"": 173, ""type"": ""Organism""}, {""token"": ""islet"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Multi""}]"
CONCLUSION: Osteopontin siRNA can inhibit U251 cells invasion via the down - regulation of uPA, MMP - 2 and MMP - 9 levels, and promote apoptosis through induction of Bax expression and inhibition of Bcl 2 level.	"Osteopontin	12	23	Gene_or_gene_product"	"U251 cells	42	52	Cell"	"uPA	91	94	Gene_or_gene_product"	"MMP - 2	96	103	Gene_or_gene_product"	"MMP - 9	108	115	Gene_or_gene_product"	"Bax	167	170	Gene_or_gene_product"	"Bcl 2	200	205	Gene_or_gene_product"	"[{""token"": ""Osteopontin"", ""start_span"": 12, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""U251 cells"", ""start_span"": 42, ""end_span"": 52, ""type"": ""Cell""}, {""token"": ""uPA"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 2"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP - 9"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bax"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl 2"", ""start_span"": 200, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}]"
Calculations of the sources of energy for adenosine triphosphate synthesis indicated that on the average about one - third of the respiratory adenosine triphosphate is generated by electron flow originating from cytosolic NADH via the malate - aspartate shuttle.	"adenosine triphosphate	42	64	Chemical"	"adenosine triphosphate	142	164	Chemical"	"electron	181	189	Chemical"	"cytosolic	212	221	Cellular_component"	"NADH	222	226	Chemical"	"malate	235	241	Chemical"	"aspartate	244	253	Chemical"	"[{""token"": ""adenosine triphosphate"", ""start_span"": 42, ""end_span"": 64, ""type"": ""Chemical""}, {""token"": ""adenosine triphosphate"", ""start_span"": 142, ""end_span"": 164, ""type"": ""Chemical""}, {""token"": ""electron"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Chemical""}, {""token"": ""cytosolic"", ""start_span"": 212, ""end_span"": 221, ""type"": ""Cellular_component""}, {""token"": ""NADH"", ""start_span"": 222, ""end_span"": 226, ""type"": ""Chemical""}, {""token"": ""malate"", ""start_span"": 235, ""end_span"": 241, ""type"": ""Chemical""}, {""token"": ""aspartate"", ""start_span"": 244, ""end_span"": 253, ""type"": ""Chemical""}]"
The treatment of ovarian cancer cells with luteinizing hormone, follicle - stimulating hormone, and estrogen induced a significant upregulation of SEMA3B, whereas SEMA3F was upregulated only by estrogen.	"ovarian cancer cells	17	37	Cell"	"luteinizing hormone	43	62	Gene_or_gene_product"	"follicle - stimulating hormone	64	94	Gene_or_gene_product"	"estrogen	100	108	Chemical"	"SEMA3B	147	153	Gene_or_gene_product"	"SEMA3F	163	169	Gene_or_gene_product"	"estrogen	194	202	Chemical"	"[{""token"": ""ovarian cancer cells"", ""start_span"": 17, ""end_span"": 37, ""type"": ""Cell""}, {""token"": ""luteinizing hormone"", ""start_span"": 43, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""follicle - stimulating hormone"", ""start_span"": 64, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen"", ""start_span"": 100, ""end_span"": 108, ""type"": ""Chemical""}, {""token"": ""SEMA3B"", ""start_span"": 147, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""SEMA3F"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Gene_or_gene_product""}, {""token"": ""estrogen"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Chemical""}]"
Using MDA - MB - 231 cells, in which FOXO3a activity can be induced by 4 - hydroxytamoxifen, we showed that FOXO3a induction up - regulates PI3K - Akt activity and enhanced doxorubicin resistance.	"MDA - MB - 231 cells	6	26	Cell"	"FOXO3a	37	43	Gene_or_gene_product"	"4 - hydroxytamoxifen	71	91	Chemical"	"FOXO3a	108	114	Gene_or_gene_product"	"PI3K	140	144	Gene_or_gene_product"	"Akt	147	150	Gene_or_gene_product"	"doxorubicin	173	184	Chemical"	"[{""token"": ""MDA - MB - 231 cells"", ""start_span"": 6, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""FOXO3a"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""4 - hydroxytamoxifen"", ""start_span"": 71, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""FOXO3a"", ""start_span"": 108, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""PI3K"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""doxorubicin"", ""start_span"": 173, ""end_span"": 184, ""type"": ""Chemical""}]"
Here, we show that the downregulation of Brk1 results in abnormal actin stress fiber formation and vinculin distribution and loss of Arp2 / 3 and Wave proteins at the cellular protrusions.	"Brk1	41	45	Gene_or_gene_product"	"actin	66	71	Gene_or_gene_product"	"stress fiber	72	84	Cellular_component"	"vinculin	99	107	Gene_or_gene_product"	"Arp2 / 3	133	141	Gene_or_gene_product"	"Wave	146	150	Gene_or_gene_product"	"cellular	167	175	Cell"	"[{""token"": ""Brk1"", ""start_span"": 41, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""actin"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""stress fiber"", ""start_span"": 72, ""end_span"": 84, ""type"": ""Cellular_component""}, {""token"": ""vinculin"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arp2 / 3"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wave"", ""start_span"": 146, ""end_span"": 150, ""type"": ""Gene_or_gene_product""}, {""token"": ""cellular"", ""start_span"": 167, ""end_span"": 175, ""type"": ""Cell""}]"
Ras p21 onco - protein in the sera of mice carrying an experimentally induced tumor and in human cancer patients.	"Ras p21	0	7	Gene_or_gene_product"	"sera	30	34	Organism_substance"	"mice	38	42	Organism"	"tumor	78	83	Cancer"	"human	91	96	Organism"	"cancer	97	103	Cancer"	"patients	104	112	Organism"	"[{""token"": ""Ras p21"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene_or_gene_product""}, {""token"": ""sera"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Organism_substance""}, {""token"": ""mice"", ""start_span"": 38, ""end_span"": 42, ""type"": ""Organism""}, {""token"": ""tumor"", ""start_span"": 78, ""end_span"": 83, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 91, ""end_span"": 96, ""type"": ""Organism""}, {""token"": ""cancer"", ""start_span"": 97, ""end_span"": 103, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 104, ""end_span"": 112, ""type"": ""Organism""}]"
By transcriptional activation and other means, p53 is able to contribute to the regulation of glycolysis, oxidative phosphorylation, glutaminolysis, insulin sensitivity, nucleotide biosynthesis, mitochondrial integrity, fatty acid oxidation, antioxidant response, autophagy and mTOR signalling.	"p53	47	50	Gene_or_gene_product"	"insulin	149	156	Gene_or_gene_product"	"nucleotide	170	180	Chemical"	"mitochondrial	195	208	Cellular_component"	"fatty acid	220	230	Chemical"	"antioxidant	242	253	Chemical"	"mTOR	278	282	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 47, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""insulin"", ""start_span"": 149, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}, {""token"": ""nucleotide"", ""start_span"": 170, ""end_span"": 180, ""type"": ""Chemical""}, {""token"": ""mitochondrial"", ""start_span"": 195, ""end_span"": 208, ""type"": ""Cellular_component""}, {""token"": ""fatty acid"", ""start_span"": 220, ""end_span"": 230, ""type"": ""Chemical""}, {""token"": ""antioxidant"", ""start_span"": 242, ""end_span"": 253, ""type"": ""Chemical""}, {""token"": ""mTOR"", ""start_span"": 278, ""end_span"": 282, ""type"": ""Gene_or_gene_product""}]"
DNA microarray analysis of treated tumor xenografts revealed significantly decreased expression of genes regulating glucose and thymidine metabolism and revealed changes in apoptotic genes, suggesting that the imaging tracers FDG, 3 - deoxy - 3 - [ ( 18) F] fluorothymidine, and annexin V could serve as potential imaging biomarkers for RAF265 therapy monitoring.	"DNA	0	3	Cellular_component"	"tumor xenografts	35	51	Cancer"	"glucose	116	123	Chemical"	"thymidine	128	137	Chemical"	"FDG	226	229	Chemical"	"annexin V	279	288	Gene_or_gene_product"	"RAF265	337	343	Chemical"	"[{""token"": ""DNA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Cellular_component""}, {""token"": ""tumor xenografts"", ""start_span"": 35, ""end_span"": 51, ""type"": ""Cancer""}, {""token"": ""glucose"", ""start_span"": 116, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""thymidine"", ""start_span"": 128, ""end_span"": 137, ""type"": ""Chemical""}, {""token"": ""FDG"", ""start_span"": 226, ""end_span"": 229, ""type"": ""Chemical""}, {""token"": ""annexin V"", ""start_span"": 279, ""end_span"": 288, ""type"": ""Gene_or_gene_product""}, {""token"": ""RAF265"", ""start_span"": 337, ""end_span"": 343, ""type"": ""Chemical""}]"
This cell line is not invasive by nature and secretes moderate amounts of VEGF - C; intrauterine injection of HEC1A cells into Balb / c nude mice resulted in uterine cancer with lymph node metastasis after 8 weeks.	"cell line	5	14	Cell"	"VEGF - C	74	82	Gene_or_gene_product"	"intrauterine	84	96	Immaterial_anatomical_entity"	"HEC1A cells	110	121	Cell"	"Balb / c nude mice	127	145	Organism"	"uterine cancer	158	172	Cancer"	"lymph node	178	188	Multi"	"[{""token"": ""cell line"", ""start_span"": 5, ""end_span"": 14, ""type"": ""Cell""}, {""token"": ""VEGF - C"", ""start_span"": 74, ""end_span"": 82, ""type"": ""Gene_or_gene_product""}, {""token"": ""intrauterine"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Immaterial_anatomical_entity""}, {""token"": ""HEC1A cells"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""Balb / c nude mice"", ""start_span"": 127, ""end_span"": 145, ""type"": ""Organism""}, {""token"": ""uterine cancer"", ""start_span"": 158, ""end_span"": 172, ""type"": ""Cancer""}, {""token"": ""lymph node"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Multi""}]"
IL - 17F ablation decreased IL - 1beta and Cox - 2 expression as well as IL - 17 receptor C ( IL - 17RC) expression, which were increased in tumors from Apc ( Min / +) mice.	"IL - 17F	0	8	Gene_or_gene_product"	"IL - 1beta	28	38	Gene_or_gene_product"	"Cox - 2	43	50	Gene_or_gene_product"	"IL - 17 receptor C	73	91	Gene_or_gene_product"	"IL - 17RC	94	103	Gene_or_gene_product"	"tumors	141	147	Cancer"	"Apc	153	156	Gene_or_gene_product"	"[{""token"": ""IL - 17F"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 1beta"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Gene_or_gene_product""}, {""token"": ""Cox - 2"", ""start_span"": 43, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 17 receptor C"", ""start_span"": 73, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""IL - 17RC"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 141, ""end_span"": 147, ""type"": ""Cancer""}, {""token"": ""Apc"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Gene_or_gene_product""}]"
Mechanistically, it reduced expression of molecular markers of cell proliferation ( Ki67) and angiogenesis ( factor VIII), antiapoptotic factor Bcl - 2, cell - cycle progression regulator cyclin D1, and survival factor AKT1.	"cell	63	67	Cell"	"Ki67	84	88	Gene_or_gene_product"	"factor VIII	109	120	Gene_or_gene_product"	"Bcl - 2	144	151	Gene_or_gene_product"	"cell	153	157	Cell"	"cyclin D1	188	197	Gene_or_gene_product"	"AKT1	219	223	Gene_or_gene_product"	"[{""token"": ""cell"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""Ki67"", ""start_span"": 84, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""factor VIII"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""Bcl - 2"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Cell""}, {""token"": ""cyclin D1"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""AKT1"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}]"
In addition to giving a historical perspective on HTLV - 1 and other retrovirus research, this paper discusses the origin of HTLV - 1; the modes of transmission and global epidemiology of HTLV - 1 infection; the genome of HTLV - 1 and the mechanism of HTLV - 1 - induced leukemogenesis; the role of HTLV - 1 in other diseases, and recent breakthroughs in ATL therapy.	"HTLV - 1	50	58	Organism"	"HTLV - 1	125	133	Organism"	"HTLV - 1	188	196	Organism"	"HTLV - 1	222	230	Organism"	"HTLV - 1	252	260	Organism"	"HTLV - 1	299	307	Organism"	"ATL	355	358	Cancer"	"[{""token"": ""HTLV - 1"", ""start_span"": 50, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 188, ""end_span"": 196, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 222, ""end_span"": 230, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 252, ""end_span"": 260, ""type"": ""Organism""}, {""token"": ""HTLV - 1"", ""start_span"": 299, ""end_span"": 307, ""type"": ""Organism""}, {""token"": ""ATL"", ""start_span"": 355, ""end_span"": 358, ""type"": ""Cancer""}]"
OSCC sublines were established from a GFP - expressing parental cell line, GSAS, and designated GSAS / N3 and N5 according to the in vivo passage number after cervical lymph node metastasis by a serial orthotopic transplantation model.	"OSCC sublines	0	13	Cell"	"GFP	38	41	Gene_or_gene_product"	"parental cell line	55	73	Cell"	"GSAS	75	79	Cell"	"GSAS / N3	96	105	Cell"	"N5	110	112	Cell"	"cervical lymph node	159	178	Multi"	"[{""token"": ""OSCC sublines"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""GFP"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""parental cell line"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""GSAS"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""GSAS / N3"", ""start_span"": 96, ""end_span"": 105, ""type"": ""Cell""}, {""token"": ""N5"", ""start_span"": 110, ""end_span"": 112, ""type"": ""Cell""}, {""token"": ""cervical lymph node"", ""start_span"": 159, ""end_span"": 178, ""type"": ""Multi""}]"
HTPB significantly suppresses tumor metastasis partly through inhibition of integrin - beta1 / FAK / MMP / RhoA / F - actin pathways.	"HTPB	0	4	Chemical"	"tumor	30	35	Cancer"	"integrin - beta1	76	92	Gene_or_gene_product"	"FAK	95	98	Gene_or_gene_product"	"MMP	101	104	Gene_or_gene_product"	"RhoA	107	111	Gene_or_gene_product"	"F - actin	114	123	Gene_or_gene_product"	"[{""token"": ""HTPB"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical""}, {""token"": ""tumor"", ""start_span"": 30, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""integrin - beta1"", ""start_span"": 76, ""end_span"": 92, ""type"": ""Gene_or_gene_product""}, {""token"": ""FAK"", ""start_span"": 95, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""MMP"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""RhoA"", ""start_span"": 107, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""F - actin"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}]"
Immunodetection was performed with a specific anti - bFGF mouse monoclonal antibody that was found to react with recombinant human bFGF in Western blot analysis, and to specifically neutralize the mitogenic activity of bFGF on bovine vascular endothelial cells.	"bFGF	53	57	Gene_or_gene_product"	"mouse	58	63	Organism"	"human	125	130	Organism"	"bFGF	131	135	Gene_or_gene_product"	"bFGF	219	223	Gene_or_gene_product"	"bovine	227	233	Organism"	"vascular endothelial cells	234	260	Cell"	"[{""token"": ""bFGF"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene_or_gene_product""}, {""token"": ""mouse"", ""start_span"": 58, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 125, ""end_span"": 130, ""type"": ""Organism""}, {""token"": ""bFGF"", ""start_span"": 131, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""bFGF"", ""start_span"": 219, ""end_span"": 223, ""type"": ""Gene_or_gene_product""}, {""token"": ""bovine"", ""start_span"": 227, ""end_span"": 233, ""type"": ""Organism""}, {""token"": ""vascular endothelial cells"", ""start_span"": 234, ""end_span"": 260, ""type"": ""Cell""}]"
The activation of Na + transport is due to the exchange of protons formed via glucose conversion into lactate for Na +, i. e., to the stimulation of the Na + / H + - antiport.	"Na +	18	22	Chemical"	"protons	59	66	Chemical"	"glucose	78	85	Chemical"	"lactate	102	109	Chemical"	"Na +	114	118	Chemical"	"Na +	153	157	Chemical"	"H +	160	163	Chemical"	"[{""token"": ""Na +"", ""start_span"": 18, ""end_span"": 22, ""type"": ""Chemical""}, {""token"": ""protons"", ""start_span"": 59, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""glucose"", ""start_span"": 78, ""end_span"": 85, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Chemical""}, {""token"": ""Na +"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""H +"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Chemical""}]"
Measuring ouabain - sensitive 22Na efflux and using ouabain - sensitive lactate production as a measure of ATP hydrolysis by the Na + K + pump, it was shown that Nonidet P - 40 greatly decreased the efficiency of the Na + K + pump.	"ouabain	10	17	Chemical"	"ouabain	52	59	Chemical"	"lactate	72	79	Chemical"	"ATP	107	110	Chemical"	"Na + K + pump	129	142	Gene_or_gene_product"	"Nonidet P - 40	162	176	Chemical"	"Na + K + pump	217	230	Gene_or_gene_product"	"[{""token"": ""ouabain"", ""start_span"": 10, ""end_span"": 17, ""type"": ""Chemical""}, {""token"": ""ouabain"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Chemical""}, {""token"": ""lactate"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Chemical""}, {""token"": ""ATP"", ""start_span"": 107, ""end_span"": 110, ""type"": ""Chemical""}, {""token"": ""Na + K + pump"", ""start_span"": 129, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}, {""token"": ""Nonidet P - 40"", ""start_span"": 162, ""end_span"": 176, ""type"": ""Chemical""}, {""token"": ""Na + K + pump"", ""start_span"": 217, ""end_span"": 230, ""type"": ""Gene_or_gene_product""}]"
Phosphorylation of Thr654 by protein kinase C decreases high affinity EGF binding and EGF - stimulated tyrosine protein kinase activity, providing a mechanism for heterologous regulation of the EGF receptor by tumor promoters and other ligand X receptor complexes.	"Thr654	19	25	Amino_acid"	"protein kinase C	29	45	Gene_or_gene_product"	"EGF	70	73	Gene_or_gene_product"	"EGF	86	89	Gene_or_gene_product"	"EGF receptor	194	206	Gene_or_gene_product"	"tumor	210	215	Cancer"	"ligand X receptor	236	253	Gene_or_gene_product"	"[{""token"": ""Thr654"", ""start_span"": 19, ""end_span"": 25, ""type"": ""Amino_acid""}, {""token"": ""protein kinase C"", ""start_span"": 29, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF"", ""start_span"": 86, ""end_span"": 89, ""type"": ""Gene_or_gene_product""}, {""token"": ""EGF receptor"", ""start_span"": 194, ""end_span"": 206, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumor"", ""start_span"": 210, ""end_span"": 215, ""type"": ""Cancer""}, {""token"": ""ligand X receptor"", ""start_span"": 236, ""end_span"": 253, ""type"": ""Gene_or_gene_product""}]"
Infection of human or murine cells with murine leukemia viruses rapidly increases the expression of a number of genes that belong to the immunoglobulin superfamily and are involved in T - lymphocyte activation, including the class I major histocompatibility complex antigens.	"human	13	18	Organism"	"murine	22	28	Organism"	"cells	29	34	Cell"	"murine leukemia viruses	40	63	Organism"	"immunoglobulin	137	151	Gene_or_gene_product"	"T - lymphocyte	184	198	Cell"	"class I major histocompatibility complex antigens	225	274	Gene_or_gene_product"	"[{""token"": ""human"", ""start_span"": 13, ""end_span"": 18, ""type"": ""Organism""}, {""token"": ""murine"", ""start_span"": 22, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""cells"", ""start_span"": 29, ""end_span"": 34, ""type"": ""Cell""}, {""token"": ""murine leukemia viruses"", ""start_span"": 40, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""immunoglobulin"", ""start_span"": 137, ""end_span"": 151, ""type"": ""Gene_or_gene_product""}, {""token"": ""T - lymphocyte"", ""start_span"": 184, ""end_span"": 198, ""type"": ""Cell""}, {""token"": ""class I major histocompatibility complex antigens"", ""start_span"": 225, ""end_span"": 274, ""type"": ""Gene_or_gene_product""}]"
This hypothesis was tested using the 2G7 IgG2b, which neutralizes TGF - beta 1, - beta 2, and - beta 3, and the MDA - 231 human breast cancer cell line.	"IgG2b	41	46	Gene_or_gene_product"	"TGF - beta 1	66	78	Gene_or_gene_product"	"- beta 2	80	88	Gene_or_gene_product"	"- beta 3	94	102	Gene_or_gene_product"	"MDA - 231	112	121	Cell"	"human	122	127	Organism"	"breast cancer cell line	128	151	Cell"	"[{""token"": ""IgG2b"", ""start_span"": 41, ""end_span"": 46, ""type"": ""Gene_or_gene_product""}, {""token"": ""TGF - beta 1"", ""start_span"": 66, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""- beta 2"", ""start_span"": 80, ""end_span"": 88, ""type"": ""Gene_or_gene_product""}, {""token"": ""- beta 3"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDA - 231"", ""start_span"": 112, ""end_span"": 121, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 122, ""end_span"": 127, ""type"": ""Organism""}, {""token"": ""breast cancer cell line"", ""start_span"": 128, ""end_span"": 151, ""type"": ""Cell""}]"
Human umbilical vein endothelial cells ( HUVECs) and rat aorta smooth muscle cells ( RASMCs) infected with AdCMV. VEGF165 ( 5 and 20 plaque - forming units [ pfu] per cell) demonstrated VEGF mRNA expression and protein secretion into the supernatant.	"Human umbilical vein endothelial cells	0	38	Cell"	"HUVECs	41	47	Cell"	"rat aorta smooth muscle cells	53	82	Cell"	"RASMCs	85	91	Cell"	"VEGF165	114	121	Gene_or_gene_product"	"cell	167	171	Cell"	"VEGF	186	190	Gene_or_gene_product"	"[{""token"": ""Human umbilical vein endothelial cells"", ""start_span"": 0, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""HUVECs"", ""start_span"": 41, ""end_span"": 47, ""type"": ""Cell""}, {""token"": ""rat aorta smooth muscle cells"", ""start_span"": 53, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""RASMCs"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 186, ""end_span"": 190, ""type"": ""Gene_or_gene_product""}]"
In contrast, neither VEGF mRNA nor secreted protein was found in uninfected HUVECs or RASMCs or in cells infected with the control vector AdCMV. beta gal ( where beta gal is beta - galactosidase).	"VEGF	21	25	Gene_or_gene_product"	"HUVECs	76	82	Cell"	"RASMCs	86	92	Cell"	"cells	99	104	Cell"	"beta gal	145	153	Gene_or_gene_product"	"beta gal	162	170	Gene_or_gene_product"	"beta - galactosidase	174	194	Gene_or_gene_product"	"[{""token"": ""VEGF"", ""start_span"": 21, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""HUVECs"", ""start_span"": 76, ""end_span"": 82, ""type"": ""Cell""}, {""token"": ""RASMCs"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Cell""}, {""token"": ""cells"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Cell""}, {""token"": ""beta gal"", ""start_span"": 145, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta gal"", ""start_span"": 162, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""beta - galactosidase"", ""start_span"": 174, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}]"
A synthetic tetracycline, doxycycline, inhibits migration of human MDA - MB - 435 breast adenocarcinoma cells through a reconstituted basement membrane ( Matrigel), an assay used as an in vitro surrogate for the in vivo process of tumor invasion through basement membranes.	"tetracycline	12	24	Chemical"	"doxycycline	26	37	Chemical"	"human	61	66	Organism"	"MDA - MB - 435 breast adenocarcinoma cells	67	109	Cell"	"basement membrane	134	151	Cellular_component"	"tumor	231	236	Cancer"	"basement membranes	254	272	Cellular_component"	"[{""token"": ""tetracycline"", ""start_span"": 12, ""end_span"": 24, ""type"": ""Chemical""}, {""token"": ""doxycycline"", ""start_span"": 26, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 61, ""end_span"": 66, ""type"": ""Organism""}, {""token"": ""MDA - MB - 435 breast adenocarcinoma cells"", ""start_span"": 67, ""end_span"": 109, ""type"": ""Cell""}, {""token"": ""basement membrane"", ""start_span"": 134, ""end_span"": 151, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Cancer""}, {""token"": ""basement membranes"", ""start_span"": 254, ""end_span"": 272, ""type"": ""Cellular_component""}]"
9E3 / CEF4, which is released from transformed chicken embryo fibroblasts ( CEF), is a member of the platelet factor 4 family of inflammatory proteins and may be the avian homolog of interleukin - 8.	"9E3	0	3	Gene_or_gene_product"	"CEF4	6	10	Gene_or_gene_product"	"chicken	47	54	Organism"	"embryo fibroblasts	55	73	Cell"	"CEF	76	79	Cell"	"platelet factor 4	101	118	Gene_or_gene_product"	"interleukin - 8	183	198	Gene_or_gene_product"	"[{""token"": ""9E3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 55, ""end_span"": 73, ""type"": ""Cell""}, {""token"": ""CEF"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Cell""}, {""token"": ""platelet factor 4"", ""start_span"": 101, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""interleukin - 8"", ""start_span"": 183, ""end_span"": 198, ""type"": ""Gene_or_gene_product""}]"
9E3 / CEF4 mRNA was expressed in chicken peripheral blood monocytes, and its expression was stimulated by incubation of the monocytes with lipopolysaccharide or phorbol myristic acetate.	"9E3	0	3	Gene_or_gene_product"	"CEF4	6	10	Gene_or_gene_product"	"chicken	33	40	Organism"	"peripheral blood monocytes	41	67	Organism_substance"	"monocytes	124	133	Cell"	"lipopolysaccharide	139	157	Chemical"	"phorbol myristic acetate	161	185	Chemical"	"[{""token"": ""9E3"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""CEF4"", ""start_span"": 6, ""end_span"": 10, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 33, ""end_span"": 40, ""type"": ""Organism""}, {""token"": ""peripheral blood monocytes"", ""start_span"": 41, ""end_span"": 67, ""type"": ""Organism_substance""}, {""token"": ""monocytes"", ""start_span"": 124, ""end_span"": 133, ""type"": ""Cell""}, {""token"": ""lipopolysaccharide"", ""start_span"": 139, ""end_span"": 157, ""type"": ""Chemical""}, {""token"": ""phorbol myristic acetate"", ""start_span"": 161, ""end_span"": 185, ""type"": ""Chemical""}]"
BACKGROUND: The murine nm23 gene suppresses the metastatic behavior of malignant rodent tumor lines, and reduced nm23 expression correlates with increased likelihood of lymph node metastases in human breast cancers.	"murine	16	22	Organism"	"nm23	23	27	Gene_or_gene_product"	"malignant rodent tumor lines	71	99	Cell"	"nm23	113	117	Gene_or_gene_product"	"lymph node	169	179	Multi"	"human	194	199	Organism"	"breast cancers	200	214	Cancer"	"[{""token"": ""murine"", ""start_span"": 16, ""end_span"": 22, ""type"": ""Organism""}, {""token"": ""nm23"", ""start_span"": 23, ""end_span"": 27, ""type"": ""Gene_or_gene_product""}, {""token"": ""malignant rodent tumor lines"", ""start_span"": 71, ""end_span"": 99, ""type"": ""Cell""}, {""token"": ""nm23"", ""start_span"": 113, ""end_span"": 117, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymph node"", ""start_span"": 169, ""end_span"": 179, ""type"": ""Multi""}, {""token"": ""human"", ""start_span"": 194, ""end_span"": 199, ""type"": ""Organism""}, {""token"": ""breast cancers"", ""start_span"": 200, ""end_span"": 214, ""type"": ""Cancer""}]"
METHODS: We used ribonuclease protection assays to analyze human colon tumors for the level of nm23 - H1 ( 43 samples) and nm23 - H2 ( 41 samples) transcript ( mRNA) expression and the presence of mutations that could inactivate potential suppressor function.	"ribonuclease	17	29	Gene_or_gene_product"	"human	59	64	Organism"	"colon tumors	65	77	Cancer"	"nm23 - H1	95	104	Gene_or_gene_product"	"samples	110	117	Cancer"	"nm23 - H2	123	132	Gene_or_gene_product"	"samples	138	145	Cancer"	"[{""token"": ""ribonuclease"", ""start_span"": 17, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 59, ""end_span"": 64, ""type"": ""Organism""}, {""token"": ""colon tumors"", ""start_span"": 65, ""end_span"": 77, ""type"": ""Cancer""}, {""token"": ""nm23 - H1"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""samples"", ""start_span"": 110, ""end_span"": 117, ""type"": ""Cancer""}, {""token"": ""nm23 - H2"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Gene_or_gene_product""}, {""token"": ""samples"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Cancer""}]"
We have investigated the putative role of rho proteins from Aplysia californica as transforming GTPases utilizing the wild - type and a Val - 14 mutant, equivalent to the oncogenic Val - 12 mutation of ras genes found in animal and human tumors.	"rho	42	45	Gene_or_gene_product"	"Aplysia californica	60	79	Organism"	"GTPases	96	103	Gene_or_gene_product"	"Val - 14 mutant	136	151	Organism"	"ras	202	205	Gene_or_gene_product"	"human	232	237	Organism"	"tumors	238	244	Cancer"	"[{""token"": ""rho"", ""start_span"": 42, ""end_span"": 45, ""type"": ""Gene_or_gene_product""}, {""token"": ""Aplysia californica"", ""start_span"": 60, ""end_span"": 79, ""type"": ""Organism""}, {""token"": ""GTPases"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""Val - 14 mutant"", ""start_span"": 136, ""end_span"": 151, ""type"": ""Organism""}, {""token"": ""ras"", ""start_span"": 202, ""end_span"": 205, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Organism""}, {""token"": ""tumors"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Cancer""}]"
OPN promoted EC migration in vitro; and VPF / VEGF induction of alphavbeta3 was accompanied by increased EC migration toward OPN.	"OPN	0	3	Gene_or_gene_product"	"EC	13	15	Cell"	"VPF	40	43	Gene_or_gene_product"	"VEGF	46	50	Gene_or_gene_product"	"alphavbeta3	64	75	Gene_or_gene_product"	"EC	105	107	Cell"	"OPN	125	128	Gene_or_gene_product"	"[{""token"": ""OPN"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 13, ""end_span"": 15, ""type"": ""Cell""}, {""token"": ""VPF"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 46, ""end_span"": 50, ""type"": ""Gene_or_gene_product""}, {""token"": ""alphavbeta3"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Cell""}, {""token"": ""OPN"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene_or_gene_product""}]"
These findings also illustrate an operational link between VPF / VEGF induction of EC gene expression and VPF / VEGF enhancement of microvascular permeability, suggesting that these distinct biological activities may act accordingly to stimulate EC migration during angiogenesis.	"VPF	59	62	Gene_or_gene_product"	"VEGF	65	69	Gene_or_gene_product"	"EC	83	85	Cell"	"VPF	106	109	Gene_or_gene_product"	"VEGF	112	116	Gene_or_gene_product"	"microvascular	132	145	Tissue"	"EC	246	248	Cell"	"[{""token"": ""VPF"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""VPF"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvascular"", ""start_span"": 132, ""end_span"": 145, ""type"": ""Tissue""}, {""token"": ""EC"", ""start_span"": 246, ""end_span"": 248, ""type"": ""Cell""}]"
Transformants induced by 5 - azacytidine lost c - myc - induced apoptotic cell death, whereas MnSO4 - induced transformants showed a higher degree of apoptosis than the parental Rat 6 / c - myc cells.	"Transformants	0	13	Cell"	"5 - azacytidine	25	40	Chemical"	"c - myc	46	53	Gene_or_gene_product"	"cell	74	78	Cell"	"MnSO4	94	99	Chemical"	"transformants	110	123	Cell"	"c - myc	186	193	Gene_or_gene_product"	"[{""token"": ""Transformants"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""5 - azacytidine"", ""start_span"": 25, ""end_span"": 40, ""type"": ""Chemical""}, {""token"": ""c - myc"", ""start_span"": 46, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 74, ""end_span"": 78, ""type"": ""Cell""}, {""token"": ""MnSO4"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Chemical""}, {""token"": ""transformants"", ""start_span"": 110, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""c - myc"", ""start_span"": 186, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}]"
To further elucidate the biological significance of WT1 in leukemic cell growth, we overexpressed exogenous WT1 in murine M1 myeloblastic leukemia cells using the isopropyl - beta - D - thiogalactoside ( IPTG) - controlled expression system.	"WT1	52	55	Gene_or_gene_product"	"cell	68	72	Cell"	"WT1	108	111	Gene_or_gene_product"	"murine	115	121	Organism"	"M1 myeloblastic leukemia cells	122	152	Cell"	"isopropyl - beta - D - thiogalactoside	163	201	Chemical"	"IPTG	204	208	Chemical"	"[{""token"": ""WT1"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Cell""}, {""token"": ""WT1"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine"", ""start_span"": 115, ""end_span"": 121, ""type"": ""Organism""}, {""token"": ""M1 myeloblastic leukemia cells"", ""start_span"": 122, ""end_span"": 152, ""type"": ""Cell""}, {""token"": ""isopropyl - beta - D - thiogalactoside"", ""start_span"": 163, ""end_span"": 201, ""type"": ""Chemical""}, {""token"": ""IPTG"", ""start_span"": 204, ""end_span"": 208, ""type"": ""Chemical""}]"
The only CD8 + CD56 + postthymic T - cell lymphoma also expressed all three cytolytic markers, two CD8 - ALCL expressed TIA1; other postthymic T - cell, T - lymphoblastic, and B - cell lymphomas were consistently negative.	"CD8	9	12	Gene_or_gene_product"	"CD56	15	19	Gene_or_gene_product"	"CD8	99	102	Gene_or_gene_product"	"TIA1	120	124	Gene_or_gene_product"	"postthymic T - cell	132	151	Cancer"	"T - lymphoblastic	153	170	Cancer"	"B - cell lymphomas	176	194	Cancer"	"[{""token"": ""CD8"", ""start_span"": 9, ""end_span"": 12, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD56"", ""start_span"": 15, ""end_span"": 19, ""type"": ""Gene_or_gene_product""}, {""token"": ""CD8"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene_or_gene_product""}, {""token"": ""TIA1"", ""start_span"": 120, ""end_span"": 124, ""type"": ""Gene_or_gene_product""}, {""token"": ""postthymic T - cell"", ""start_span"": 132, ""end_span"": 151, ""type"": ""Cancer""}, {""token"": ""T - lymphoblastic"", ""start_span"": 153, ""end_span"": 170, ""type"": ""Cancer""}, {""token"": ""B - cell lymphomas"", ""start_span"": 176, ""end_span"": 194, ""type"": ""Cancer""}]"
Simian virus 40 large T antigen ( SV40 Tag) was introduced into a normal human first trimester invasive EVT cell line, HTR8, established in our laboratory.	"Simian virus 40	0	15	Organism"	"large T antigen	16	31	Gene_or_gene_product"	"SV40	34	38	Organism"	"Tag	39	42	Gene_or_gene_product"	"human	73	78	Organism"	"EVT cell line	104	117	Cell"	"HTR8	119	123	Cell"	"[{""token"": ""Simian virus 40"", ""start_span"": 0, ""end_span"": 15, ""type"": ""Organism""}, {""token"": ""large T antigen"", ""start_span"": 16, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 34, ""end_span"": 38, ""type"": ""Organism""}, {""token"": ""Tag"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organism""}, {""token"": ""EVT cell line"", ""start_span"": 104, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""HTR8"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Cell""}]"
RNA encoding glucokinase ( GK), the high - Km HK isozyme, was found only in cancer cells originating from liver and pancreas, which express GK under normal conditions.	"glucokinase	13	24	Gene_or_gene_product"	"GK	27	29	Gene_or_gene_product"	"HK	46	48	Gene_or_gene_product"	"cancer cells	76	88	Cell"	"liver	106	111	Organ"	"pancreas	116	124	Organ"	"GK	140	142	Gene_or_gene_product"	"[{""token"": ""glucokinase"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Gene_or_gene_product""}, {""token"": ""GK"", ""start_span"": 27, ""end_span"": 29, ""type"": ""Gene_or_gene_product""}, {""token"": ""HK"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cells"", ""start_span"": 76, ""end_span"": 88, ""type"": ""Cell""}, {""token"": ""liver"", ""start_span"": 106, ""end_span"": 111, ""type"": ""Organ""}, {""token"": ""pancreas"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Organ""}, {""token"": ""GK"", ""start_span"": 140, ""end_span"": 142, ""type"": ""Gene_or_gene_product""}]"
MATERIALS AND METHODS: U - 995 was designed to study human umbilical vein endothelial cell ( HUVEC) migration and proliferation in vitro and angiogenesis induced by TNF alpha in chicken chorioallantoic membrane ( CAM).	"U - 995	23	30	Gene_or_gene_product"	"human umbilical vein endothelial cell	53	90	Cell"	"HUVEC	93	98	Cell"	"TNF alpha	165	174	Gene_or_gene_product"	"chicken	178	185	Organism"	"chorioallantoic membrane	186	210	Multi"	"CAM	213	216	Multi"	"[{""token"": ""U - 995"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""human umbilical vein endothelial cell"", ""start_span"": 53, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""HUVEC"", ""start_span"": 93, ""end_span"": 98, ""type"": ""Cell""}, {""token"": ""TNF alpha"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Gene_or_gene_product""}, {""token"": ""chicken"", ""start_span"": 178, ""end_span"": 185, ""type"": ""Organism""}, {""token"": ""chorioallantoic membrane"", ""start_span"": 186, ""end_span"": 210, ""type"": ""Multi""}, {""token"": ""CAM"", ""start_span"": 213, ""end_span"": 216, ""type"": ""Multi""}]"
